-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Koe2FBjmrQTHK+yl8lB6wKHkdPs52IaZDvqltPQ0QPRNgNUKHBcsYnEA5lZ6I+Ur 069XJHDVGju+fhBCuC3ipg== 0001193125-09-098817.txt : 20090505 0001193125-09-098817.hdr.sgml : 20090505 20090505073312 ACCESSION NUMBER: 0001193125-09-098817 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20090505 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20090505 DATE AS OF CHANGE: 20090505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 09795402 BUSINESS ADDRESS: STREET 1: 13737 NOEL ROAD CITY: DALLAS STATE: TX ZIP: 75240 BUSINESS PHONE: 469-893-2200 MAIL ADDRESS: STREET 1: 13737 NOEL ROAD CITY: DALLAS STATE: TX ZIP: 75240 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report: May 5, 2009

(Date of earliest event reported)

 

 

TENET HEALTHCARE CORPORATION

(Exact name of Registrant as specified in its charter)

 

 

 

Nevada   1-7293   95-2557091
(State of Incorporation)   (Commission File Number)  

(IRS Employer

Identification Number)

13737 Noel Road

Dallas, Texas 75240

(Address of principal executive offices, including zip code)

(469) 893-2200

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02 Results of Operations and Financial Condition.

The information contained herein is being furnished pursuant to Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

On May 5, 2009, Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of the Company for the quarter ended March 31, 2009. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

  (d) Exhibits

 

99.1    Press Release issued on May 5, 2009

 

- 2 -


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TENET HEALTHCARE CORPORATION
  By:  

/s/ Biggs C. Porter

    Biggs C. Porter
    Chief Financial Officer
Date: May 5, 2009    

 

- 3 -


EXHIBIT INDEX

 

99.1    Press Release issued on May 5, 2009

 

- 4 -

EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

 

LOGO    LOGO

 

         Headquarters Office
        

13737 Noel Road,

Ste.100

Dallas, TX 75240

tel: 469.893.2000

fax: 469.893.8600

www.tenethealth.com

 

   Contacts:  
           Media:   David Matthews (469) 893-2640
     David.Matthews@tenethealth.com
           Investors:   Thomas Rice (469) 893-2522
     Thomas.Rice@tenethealth.com

Tenet Reports Results for First Quarter Ended March 31, 2009

Highlights:

 

 

$276 million in total adjusted EBITDA, an increase of 28.4 percent; $273 million in same-hospital adjusted EBITDA, an increase of 25.8 percent

 

 

Net income attributable to shareholders of $178 million, an increase of $209 million

 

 

Reduced cash consumption by $151 million, or 52.8 percent: $135 million use of cash in adjusted free cash flow from continuing operations; net cash used in operating activities was $6 million in the first quarter of 2009 compared to $133 million in the first quarter of 2008

 

 

$652 million in cash and equivalents at Mar. 31, 2009, an increase of $145 million from Dec. 31, 2008

 

 

1.3 percent decrease in same-hospital paying admissions, approximately 0.1 percent decrease after adjusting for the extra weekday in 2008’s first quarter due to Leap Year

 

   

1.3 percent decrease in same-hospital total admissions, approximately 0.1 percent decrease adjusted for Leap Year

 

 

2.3 percent increase in same-hospital paying outpatient visits, approximately 3.4 percent increase adjusted for Leap Year

 

   

0.7 percent increase in total same-hospital outpatient visits, approximately 1.8 percent increase adjusted for Leap Year

 

 

2.6 percent increase in same-hospital total surgeries, approximately 3.7 percent adjusted for Leap Year

 

   

4.7 percent increase in same-hospital outpatient surgeries, approximately 5.8 percent increase adjusted for Leap Year

 

 

3.2 percent decrease in same-hospital commercial managed care admissions, approximately 2.0 percent decrease adjusted for Leap Year

 

   

1.5 percent decrease in same-hospital commercial managed care outpatient visits, approximately 0.4 percent decrease adjusted for Leap Year

 

 

4.5 percent increase in same-hospital commercial managed care revenues

 

 

$101 million in capital expenditures in continuing operations

 

 

Bad debt ratio of 6.8 percent of net revenues, an increase of 10 basis points from 6.7 percent in Q1’08

DALLAS – May 5, 2009 – Tenet Healthcare Corporation (NYSE:THC) today reported net income attributable to shareholders of $178 million, or $0.37 per share, for its first quarter of 2009, compared to a net loss attributable to shareholders of $31 million, or $0.06 per share, for its first quarter of 2008. Adjusted EBITDA, a non-GAAP term defined below, was $276 million for the first quarter of 2009, an increase of $61 million, or 28.4


percent, as compared to $215 million for the first quarter of 2008. On a same-hospital basis, adjusted EBITDA was $273 million, an increase of $56 million, or 25.8 percent, as compared to $217 million in the first quarter of 2008.

“Excellent cost control at all levels of our enterprise led to a very strong first quarter with adjusted EBITDA growing by 28 percent compared to the first quarter of 2008,” said Trevor Fetter, president and chief executive officer. “Cash flow was also solid, driven by increased earnings and careful control of working capital and capital expenditures. While there is no question that a weak economy continues to have an adverse impact on patient volumes, our many initiatives to better serve our communities and physicians kept volume declines to a minimum, with total admissions declining by just 1.3 percent from the first quarter of 2008, or virtually flat after adjusting for the loss of the Leap Year day versus 2008. I am also pleased that our multi-year efforts to improve clinical quality and patient safety once again drove a strong year-over-year reduction in our malpractice costs. The weak economy, and specifically growing unemployment, remains a cause for concern for two key drivers of our business: commercial managed care volumes and bad debt expense. In fact, while our trends in total admissions and outpatient visits were stronger in the month of April than in the first quarter, April’s commercial managed care admissions were lower than expected. While we remain cautious regarding the potential for increasing pressure from a softer economy, we are raising our outlook for 2009 adjusted EBITDA by $25 million to a range of $760 million to $825 million.”

Continuing Operations

Net income attributable to shareholders was $178 million in the first quarter of 2009, or $0.37 per share, including the following items with an aggregate, net favorable impact of $141 million after-tax, or $0.29 per share:

 

  1. Loss from discontinued operations net of tax of $11 million, or $0.02 per share;

 

  2. Favorable income tax adjustments of $72 million, or $0.14 per share, primarily related to a decrease in the Company’s valuation allowance for deferred tax assets and other tax adjustments;

 

  3. Litigation and investigation costs of $1 million pre-tax, $1 million after-tax before the deferred tax valuation allowance, or zero cents per share;

 

  4. Impairment of long lived-assets and goodwill and restructuring charges of $5 million pre-tax, $3 million after-tax before the tax valuation allowance, or $0.01 per share; and

 

  5. Gain from early extinguishment of debt of $134 million pre-tax, $84 million after-tax before the deferred tax valuation allowance, or $0.18 per share.

Adjusted EBITDA

Adjusted EBITDA, a non-GAAP term defined below, was $276 million, or a margin of 12.1 percent of net operating revenues, in the first quarter of 2009. This represents an increase of $61 million, or 28.4 percent, from adjusted EBITDA of $215 million in the first quarter of 2008, and margin increase of 220 basis points as compared to an adjusted EBITDA margin of 9.9 percent in the first quarter of 2008.

Same-hospital adjusted EBITDA was $273 million in the first quarter of 2009, an increase of $56 million, or 25.8 percent, from the $217 million in the first quarter of 2008. Same-hospital adjusted EBITDA margin increased by 210 basis points to 12.1 percent in the first quarter of 2009 as compared to the same-hospital adjusted EBITDA margin of 10.0 percent in the first quarter of 2008. Same-hospital financial data excludes the results from one of our hospitals as discussed below.

Adjusted EBITDA is a non-GAAP term defined by the Company as net income (loss) attributable to shareholders before: (1) the cumulative effect of changes in accounting principle, net of tax; (2) net income attributable to noncontrolling interests (3) income (loss) from discontinued operations, net of tax; (4) income tax (expense) benefit; (5) net gains (losses) on sales of investments; (6) investment earnings; (7) gain from early extinguishment of debt; (8) interest expense; (9) litigation and investigation (costs) benefit, net of insurance recoveries; (10) hurricane insurance recoveries, net of costs; (11) impairment of long-lived assets and goodwill

 

- 2 -


and restructuring charges, net of insurance recoveries; (12) amortization; and (13) depreciation. A reconciliation of adjusted EBITDA to net income (loss) attributable to Tenet Healthcare Corporation shareholders is provided in Table #1 at the end of this release.

Same-Hospital Data

Same-hospital continuing operations data excludes Sierra Providence East Medical Center, in El Paso, which opened on May 21, 2008. Same-hospital continuing operations data is the primary form of tabular data presentation in the narrative sections of this document. There are currently 49 hospitals in same-hospital continuing operations.

Total-hospital data, including the contribution of Sierra Providence East Medical Center, is provided in the tabular presentation of data at the end of this document. As a result of this approach, certain amounts in the narrative section of this document will not tie to amounts in the condensed consolidated statement of operations.

Admissions, Patient Days and Surgeries

 

Admissions, Patient Days and Surgeries

       Same-Hospital
Continuing Operations
 
     Q1’09    Q1’08    Change (%)  

Commercial Managed Care Admissions

     34,468    35,616    (3.2 )

Governmental Managed Care Admissions

     30,727    27,981    9.8  

Medicare Admissions

     42,449    44,634    (4.9 )

Medicaid Admissions

     16,027    16,829    (4.8 )

Uninsured Admissions

     5,518    5,894    (6.4 )

Charity Care Admissions

     2,601    2,379    9.3  

Other Admissions

     3,533    3,774    (6.4 )

Total Admissions

     135,323    137,107    (1.3 )

Paying Admissions (excludes Charity + Uninsured)

     127,204    128,834    (1.3 )

Charity Admissions + Uninsured Admissions

     8,119    8,273    (1.9 )

Admissions through Emergency Department

     78,074    78,380    (0.4 )

Commercial Managed Care Admits / Total Admits

  (%)    25.5    26.0    (0.5 (a)

Emergency Department Admissions / Total Admits

  (%)    57.7    57.2    0.5  (a)

Uninsured Admissions / Total Admissions

  (%)    4.1    4.3    (0.2 (a)

Charity Admissions / Total Admissions

  (%)    1.9    1.7    0.2  (a)

Surgeries – Inpatient

     38,468    38,508    (0.1 )

Surgeries – Outpatient

     51,835    49,507    4.7  

Surgeries – Total

     90,303    88,015    2.6  

Patient Days – Total

     674,099    697,274    (3.3 )

Adjusted Patient Days (b)

     980,360    983,127    (0.3 )

Patient Days – Commercial Managed Care

     142,044    147,283    (3.6 )

Average Length of Stay

  (days)    5.0    5.1    (0.1 (a)

Adjusted Patient Admissions (b)

     197,928    194,592    1.7  

 

(a)    This change is the difference between the Q1’09 and Q1’08 amounts shown

(b)    “Adjusted Patient Days / Admissions” represents actual patient days / admissions adjusted to include outpatient services by multiplying actual patient days / admissions by the sum of gross inpatient revenues and outpatient revenues and dividing the results by gross inpatient revenues.

      

        

Our Central Region achieved positive admissions growth in the quarter, but admissions declines were recorded in Tenet’s other regions.

Commercial managed care admissions declined by 3.2 percent compared to the first quarter of 2008. The decline is 2.0 percent after adjustment for the Leap Year effect. The 2.0 percent adjusted decline represents an improvement in the trend of commercial admissions in recent quarters.

 

- 3 -


Surgery growth remained strong supported by growth in outpatient surgeries of 4.7 percent. Inpatient surgeries were essentially flat relative to the first quarter of 2008.

Outpatient Visits

 

Outpatient Visits

       Same-Hospital
Continuing Operations
 
     Q1’09    Q1’08    Change (%)  

Total OP Visits

     972,047    965,200    0.7  

Paying OP Visits (excludes Uninsured + Charity)

     873,084    853,417    2.3  

Uninsured OP Visits

     91,358    106,063    (13.9 )

Uninsured OP Visits / Total OP Visits

  (%)    9.4    11.0    (1.6 (a)

Charity Care OP Visits

     7,605    5,720    33.0  

Charity Care OP Visits / Total OP Visits

  (%)    0.8    0.6    0.2  (a)

Charity OP Visits + Uninsured OP Visits

     98,963    111,783    (11.5 )

OP Surgery Visits

     51,835    49,507    4.7  

Commercial Managed Care OP Visits

     347,770    352,887    (1.5 )

Commercial OP Visits / Total Visits

  (%)    35.8    36.6    (0.8 (a)

 

(a)    This change is the difference between the Q1’09 and Q1’08 amounts shown.

          

Total same-hospital outpatient visits increased by 0.7 percent and paying outpatient visits (excluding uninsured and charity outpatient visits) increased by 2.3 percent in the first quarter of 2009 as compared to the first quarter of 2008. After adjustment for the Leap Year effect, total same-hospital outpatient visits increased by 1.8 percent compared to the first quarter of 2008 and paying outpatient visits increased by 3.4 percent. Tenet has now reported year-over-year growth in outpatient visits in three of the last four quarters. Outpatient surgery visits showed robust growth with an increase of 4.7 percent compared to the first quarter of 2008.

The impact of new outpatient centers on visits was approximately offset by the loss of outpatient visits from outpatient centers that were either closed or divested since the first quarter of 2008.

Commercial managed care outpatient visits declined by 5,117 visits, or 1.5 percent, compared to the first quarter of 2008. In addition to the Leap Year effect with an estimated adverse impact on commercial managed care outpatient visits of approximately 3,800 visits, commercial managed care emergency department visits declined by 4,703 visits, or 5 percent. This decline in commercial managed care outpatient visits to the emergency department is believed to be related to the weak economic environment as well as the migration of certain emergency department visits to alternative sites for care. Total emergency department visits across all payer classes increased by 1,628 visits, or 0.5 percent. The total of charity and uninsured outpatient visits declined by 12,820 visits, or 11.5 percent.

Our Central and Florida Regions as well as our Philadelphia Market all reported growth in outpatient visits in excess of three percent, while declines were reported in our California and Southern States Regions.

 

- 4 -


Revenues

 

Revenues ($ in millions)

   Same-Hospital
Continuing Operations
 
   Q1’09    Q1’08    Change (%)  

Net Operating Revenues

   2,257    2,178    3.6  

Net Patient Revenue from Commercial Managed Care

   882    844    4.5  

Revenues from the Uninsured

   142    158    (10.1 )

Prior-year cost report adjustments contributed $11 million to net operating revenues in the first quarter of 2009. Prior-year cost report adjustments made no material contribution to net operating revenues in the first quarter of 2008.

Pricing

 

Pricing ($)

   Same-Hospital
Continuing Operations
   Q1’09    Q1’08    Change (%)

Net Inpatient Revenue per Admission

   11,173    10,780    3.6

Net Inpatient Revenue per Patient Day

   2,243    2,120    5.8

Net Outpatient Revenue per Visit

   684    650    5.2

Net Patient Revenue per Adjusted Patient Admission

   10,999    10,818    1.7

Net Patient Revenue per Adjusted Patient Day

   2,221    2,141    3.7

Managed Care: Net Inpatient Revenue per Admission

   11,930    11,548    3.3

Managed Care: Net Outpatient Revenue per Visit

   807    770    4.8

Pricing improvement was evident across all key metrics, primarily reflecting the improved terms of our commercial managed care contracts. The growth in net inpatient revenue per admission of 3.6 percent was constrained by the decline in commercial managed care admissions of 3.2 percent compared to the first quarter of 2008.

Controllable Operating Expenses

 

Controllable Operating Expenses

       Same-Hospital
Continuing Operations
 
     Q1’09    Q1’08    Change (%)  

Salaries, Wages & Benefits

  ($mm)    967    953    1.5  

Supplies

  ($mm)    392    379    3.4  

Other Operating Expenses

  ($mm)    472    482    (2.1 )

Total Controllable Operating Expenses

  ($mm)    1,831    1,814    0.9  

Rent / Lease Expense (a)

  ($mm)    36    35    2.9  

Unit Cost Statistics

          

Salaries, Wages & Benefits per Adjusted Patient Day

  ($)    986    969    1.8  

Supplies per Adjusted Patient Day

  ($)    400    386    3.6  

Other Operating Expenses per Adjusted Patient Day

  ($)    481    490    (1.8 )

Total Controllable Operating Expenses per Adjusted Patient Day

  ($)    1,867    1,845    1.2  

 

(a)

Included in Other Operating Expenses

We define controllable operating expenses as salaries, wages & benefits, supplies, and other operating expenses. Total controllable operating expenses per adjusted patient day increased by 1.2 percent compared to the first quarter of 2008.

 

- 5 -


Salaries, wages and benefits per adjusted patient day increased by 1.8 percent compared to the first quarter of 2008. This increase is primarily due to merit increases for our employees and increased health benefits costs, partially offset by a decline in full-time employee headcount, reduced contract labor expense, lower stock compensation expense, a lower 401(k) match expense effective January 1, 2009, and lower overtime costs. Contract labor expense, which is included in salaries, wages and benefits, was $29 million in the first quarter of 2009, a decrease of $14 million, or 33 percent, compared to the first quarter of 2008.

Supplies expense per adjusted patient day increased by 3.6 percent compared to the first quarter of 2008. The increase in supplies expense is primarily due to the increased number of surgeries, and increased utilization of high cost implants and high cost drugs. A portion of the increase in supplies expense is offset by revenue growth related to payments we receive from certain payers.

Other operating expenses per adjusted patient day decreased by 1.8 percent compared to the first quarter of 2008. Contributing to this decrease was a $19 million, or 48 percent, decline in total hospital malpractice expense to $21 million, compared to $40 million in the first quarter of 2008. This decrease is primarily attributable to improved claims experience. A decline in consulting costs also had a favorable impact on other operating expenses. The favorable impact of these items was partially offset by increases in other items, including higher physician fees related to increased Emergency Department on-call payments and increases in the costs of contracted services.

Provision for Doubtful Accounts

 

Bad Debt

       Same-Hospital
Continuing Operations
 
     Q1’09    Q1’08    Change (%)  

Provision for Doubtful Accounts (“Bad Debt”)

  ($mm)    153    147    4.1  

Bad Debt / Net Operating Revenues

  (%)    6.8    6.7    0.1 (a)

Collection Rate from Self-Pay

  (%)    31.4    35.0    (3.6 )(a)

Collection Rate from Managed Care Payers

  (%)    97.9    98.3    (0.4 )(a)

 

(a)

This change is the difference between the Q1’09 and Q1’08 amounts shown.

Bad debt expense increased by $6 million, or 4.1 percent, compared to the first quarter of 2008. The increase in bad debt expense was related to decreased collection rates from uninsured accounts, higher pricing, and higher patient insurance deductibles, partially offset by the decline in uninsured revenues. Our self-pay collection rate declined to approximately 31.4 percent in the first quarter of 2009 compared to 35.0 percent in the first quarter of 2008, and 32.5 percent in the fourth quarter of 2008. Bad debt expense in the first quarter of 2008 benefited from a $7 million favorable settlement of a dispute with a managed care payer.

Accounts Receivable

Consolidated accounts receivable were $1.385 billion at March 31, 2009 and $1.337 billion at December 31, 2008. Accounts receivable days outstanding from continuing operations were 50 days at March 31, 2009 and December 31, 2008 compared to 52 days at March 31, 2008. This amount is calculated as accounts receivable from continuing operations divided by net revenue from continuing operations divided by the number of days in the quarter.

Cash Flow

Cash and cash equivalents were $652 million at March 31, 2009, an increase of $145 million from $507 million at December 31, 2008. Adjusted Free Cash Flow, a non-GAAP term defined below, was negative $135 million in the first quarter of 2009 compared to negative $286 million in the first quarter of 2008. Net cash used in operating activities was $6 million in the first quarter of 2009 compared to $133 million in the first quarter of 2008.

 

- 6 -


Adjusted Free Cash Flow, a non-GAAP term, is defined by the Company as cash flows provided by (used in) operating activities less (1) capital expenditures in continuing operations, (2) new and replacement hospital construction expenditures, (3) income tax refunds (payments), (4) net cash provided by (used in) operating activities from discontinued operations, and (5) payments against reserves for restructuring charges, litigation costs and settlements. The reconciliation of net cash provided by (used in) operating activities, the most comparable GAAP term, to Adjusted Free Cash Flow is provided in Table #2 below.

Significant cash flow items in the first quarter of 2009 included:

 

  (1) $123 million in aggregate annual 401(k) matching contributions and annual incentive compensation payments, which were accrued as compensation expense in 2008;

 

  (2) Capital expenditures of $102 million, consisting of $101 million in continuing operations and $1 million in discontinued operations;

 

  (3) Interest payments of $149 million;

 

  (4) A $57 million increase in the cash and cash equivalents balance related to our Medicare HMO insurance subsidiary operating in Louisiana primarily due to the timing of monthly payments from CMS;

 

  (5) Proceeds of $251 million from sales of facilities and other assets related to discontinued operations, primarily from the sale of USC University Hospital and USC Kenneth Norris Jr. Cancer Hospital;

 

  (6) $23 million in principal payments (excluding interest of $2 million) classified as operating cash outflows from continuing operations related to our 2006 civil settlement with the federal government;

 

  (7) Cash distributions of $8 million we received related to our investment in the Reserve Yield Plus Fund, which are classified as investing activity cash flows; and

 

  (8) $10 million of cash received with respect to a residency program funding grant agreement between our Doctors Medical Center in Modesto, California and the local county.

Outlook for 2009

The Company’s outlook for 2009 is materially dependent on a number of items that are difficult to project given the uncertain macro-economic environment. Among the most important of these items are aggregate patient volumes, payer and patient mix, and bad debt expense.

Based on stronger than anticipated results for the first quarter of 2009, we are raising our 2009 outlook range for adjusted EBITDA by $25 million from the prior range of $735 million to $800 million, to $760 million to $825 million. Our outlook for net income attributable to shareholders for 2009 is in a range of a loss of $50 million to positive net income of $80 million.

A reconciliation of outlook adjusted EBITDA to outlook net income (loss) attributable to shareholders for year ending December 31, 2009 is provided in Table #3.

Management’s Webcast Discussion of First Quarter Results

Tenet management will discuss first quarter 2009 results on a webcast scheduled to begin at 10:00 AM (ET) on May 5, 2009. This webcast may be accessed through Tenet’s website at www.tenethealth.com. A set of slides accompanying the call will be posted to the Company’s website at approximately 7:30 AM (ET).

 

- 7 -


Tenet Healthcare Corporation, through its subsidiaries, owns and operates acute care hospitals and related ancillary health care businesses, which include ambulatory surgery centers and diagnostic imaging centers. Tenet’s hospitals and related healthcare facilities are committed to providing high quality care to patients in the communities we serve. For more information, please visit www.tenethealth.com.

# # #

Some of the statements in this release may constitute forward-looking statements. Such forward-looking statements are based on our current expectations and could be affected by numerous factors and are subject to various risks and uncertainties discussed in our filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended Dec. 31, 2008, our quarterly reports on Form 10-Q, and periodic reports on Form 8-K. Do not rely on any forward-looking statement, as we cannot predict or control many of the factors that ultimately may affect our ability to achieve the results estimated. We make no promise to update any forward-looking statement, whether as a result of changes in underlying factors, new information, future events or otherwise.

 

- 8 -


TENET HEALTHCARE CORPORATION

CONSOLIDATED OPERATIONS DATA

(Unaudited)

 

      Three Months Ended March 31,  
(Dollars in millions except per share amounts)    2009     %     2008     %     Change  

Net operating revenues

   $ 2,279     100.0 %   $ 2,178     100.0 %   4.6 %

Operating expenses:

          

Salaries, wages and benefits

     (975 )   (42.8 )%     (954 )   (43.8 )%   2.2 %

Supplies

     (395 )   (17.3 )%     (379 )   (17.4 )%   4.2 %

Provision for doubtful accounts

     (156 )   (6.8 )%     (147 )   (6.7 )%   6.1 %

Other operating expenses, net

     (477 )   (21.0 )%     (483 )   (22.3 )%   (1.2 )%

Depreciation

     (86 )   (3.8 )%     (82 )   (3.8 )%   4.9 %

Amortization

     (11 )   (0.5 )%     (8 )   (0.3 )%   37.5 %

Impairment of long-lived assets and goodwill, and restructuring charges

     (5 )   (0.2 )%     (1 )   —      

Litigation and investigation costs

     (1 )   —         (47 )   (2.2 )%  
                              

Operating income

     173     7.6 %     77     3.5 %  

Interest expense

     (110 )       (104 )    

Gain from early extinguishment of debt

     134         —        

Investment earnings

     2         5      
                      

Income (loss) from continuing operations, before income taxes

     199         (22 )    

Income tax expense

     (5 )       (1 )    
                      

Income (loss) from continuing operations, before discontinued operations

     194         (23 )    

Discontinued operations:

          

Income from operations

     2         5      

Impairment of long-lived assets and goodwill, and restructuring charges

     (9 )       (10 )    

Net losses on sales of facilities

     (2 )       —        

Income tax expense

     (2 )       (2 )    
                      

Loss from discontinued operations

     (11 )       (7 )    
                      

Net income (loss)

     183         (30 )    

Less: Net income attributable to noncontrolling interests

     5         1      
                      

Net income (loss) attributable to Tenet Healthcare Corporation shareholders

   $ 178       $ (31 )    
                      

Earnings (loss) per share attributable to Tenet Healthcare Corporation shareholders

          

Basic

          

Continuing operations

   $ 0.40       $ (0.05 )    

Discontinued operations

     (0.02 )       (0.01 )    
                      
   $ 0.38       $ (0.06 )    
                      

Diluted

          

Continuing operations

   $ 0.39       $ (0.05 )    

Discontinued operations

     (0.02 )       (0.01 )    
                      
   $ 0.37       $ (0.06 )    
                      

Weighted average shares and dilutive securities outstanding (in thousands):

          

Basic

     478,372         475,066      

Diluted

     479,512         475,066      

 

- 9 -


TENET HEALTHCARE CORPORATION

CONSOLIDATED BALANCE SHEET DATA

(Unaudited)

 

(Dollars in Millions)    March 31,
2009
    December 31,
2008
 
ASSETS     

Current assets:

    

Cash and cash equivalents

   $ 652     $ 507  

Investments in Reserve Yield Plus Fund

     6       14  

Investments in marketable debt securities

     1       2  

Accounts receivable, less allowance for doubtful accounts

     1,385       1,337  

Inventories of supplies, at cost

     158       161  

Income tax receivable

     5       6  

Deferred income taxes

     82       82  

Assets held for sale

     35       310  

Other current assets

     307       290  
                

Total current assets

     2,631       2,709  

Investments and other assets

     255       242  

Property and equipment, at cost, less accumulated depreciation and amortization

     4,236       4,291  

Goodwill

     609       609  

Other intangible assets, at cost, less accumulated amortization

     361       323  
                

Total assets

   $ 8,092     $ 8,174  
                
LIABILITIES AND EQUITY     

Current liabilities:

    

Current portion of long-term debt

   $ 2     $ 2  

Accounts payable

     650       686  

Accrued compensation and benefits

     328       414  

Professional and general liability reserves

     116       127  

Accrued interest payable

     77       125  

Accrued legal settlement costs

     168       168  

Other current liabilities

     494       427  
                

Total current liabilities

     1,835       1,949  

Long-term debt, net of current portion

     4,639       4,778  

Professional and general liability reserves

     527       536  

Accrued legal settlement costs

     49       72  

Other long-term liabilities

     598       591  

Deferred income taxes

     106       101  
                

Total liabilities

     7,754       8,027  

Commitments and contingencies

    

Equity:

    

Shareholders’ equity:

    

Common stock

     26       26  

Additional paid-in capital

     4,450       4,445  

Accumulated other comprehensive loss

     (34 )     (37 )

Accumulated deficit

     (2,674 )     (2,852 )

Less common stock in treasury, at cost

     (1,477 )     (1,479 )
                

Total shareholders’ equity

     291       103  

Noncontrolling interests

     47       44  
                

Total equity

     338       147  
                

Total liabilities and equity

   $ 8,092     $ 8,174  
                

 

- 10 -


TENET HEALTHCARE CORPORATION

CONSOLIDATED CASH FLOW DATA

(Unaudited)

 

(Dollars in Millions)    Three Months Ended
March 31,
 
     2009     2008  

Net income (loss)

   $ 183     $ (30 )

Adjustments to reconcile net income (loss) to net cash from operating activities:

    

Depreciation and amortization

     97       90  

Provision for doubtful accounts

     156       147  

Deferred income tax expense

     3       21  

Stock-based compensation expense

     7       10  

Impairment of long-lived assets and goodwill, and restructuring charges

     5       1  

Litigation and investigation costs

     1       47  

Gain from early extinguishment of debt

     (134 )     —    

Pretax loss from discontinued operations

     9       5  

Other items, net

     9       1  

Changes in cash from changes in operating assets and liabilities:

    

Accounts receivable

     (229 )     (222 )

Inventories and other current assets

     (16 )     3  

Income taxes

     4       (17 )

Accounts payable, accrued expenses and other current liabilities

     (117 )     (155 )

Other long-term liabilities

     (12 )     —    

Payments against reserves for restructuring charges and litigation costs

     (28 )     (27 )

Net cash provided by (used in) operating activities from discontinued operations, excluding income taxes

     56       (7 )
                

Net cash used in operating activities

     (6 )     (133 )

Cash flows from investing activities:

    

Purchases of property and equipment:

    

Continuing operations

     (85 )     (157 )

Discontinued operations

     (1 )     (2 )

Construction of new and replacement hospitals

     (16 )     (29 )

Proceeds from sales of facilities and other assets – discontinued operations

     251       23  

Proceeds from sales of marketable securities, long-term investments and other assets

     18       9  

Purchases of marketable securities

     —         (7 )

Distributions received from investments in Reserve Yield Plus Fund

     8       —    

Other items, net

     (1 )     2  
                

Net cash provided by (used in) investing activities

     174       (161 )

Cash flows from financing activities:

    

Repayments of borrowings

     (1 )     (1 )

Deferred debt issuance costs

     (22 )     —    

Dividends paid to the noncontrolling interests

     (2 )     —    

Other items, net

     2       1  
                

Net cash used in financing activities

     (23 )     —    
                

Net increase (decrease) in cash and cash equivalents

     145       (294 )

Cash and cash equivalents at beginning of period

     507       572  
                

Cash and cash equivalents at end of period

   $ 652     $ 278  
                

Supplemental disclosures:

    

Interest paid, net of capitalized interest

   $ (149 )   $ (125 )

Income tax refunds, net

   $ —       $ 1  

 

- 11 -


TENET HEALTHCARE CORPORATION

SELECTED STATISTICS – CONTINUING SAME HOSPITALS

(Unaudited)

 

      Three Months Ended March 31,      
      2009     2008     Change      

Net inpatient revenues

   $ 1,512     $ 1,478     2.3 %  

Net outpatient revenues

   $ 665     $ 627     6.1 %  

Number of general hospitals (at end of period)

     49       49     —       *

Licensed beds (at end of period)

     13,470       13,438     0.2 %  

Average licensed beds

     13,464       13,457     0.1 %  

Utilization of licensed beds

     55.6 %     56.9 %   (1.3 %)   *

Patient days

     674,099       697,274     (3.3 %)  

Adjusted patient days

     980,360       983,127     (0.3 )%  

Net inpatient revenue per patient day

   $ 2,243     $ 2,120     5.8 %  

Admissions

     135,323       137,107     (1.3 %)  

Adjusted patient admissions

     197,928       194,592     1.7 %  

Net inpatient revenue per admission

   $ 11,173     $ 10,780     3.6 %  

Average length of stay (days)

     5.0       5.1     (0.1 )   *

Surgeries

     90,303       88,015     2.6 %  

Net outpatient revenue per visit

   $ 684     $ 650     5.2 %  

Outpatient visits

     972,047       965,200     0.7 %  

Sources of net patient revenue

        

Medicare

     26.9 %     26.2 %   0.7 %   *

Medicaid

     8.0 %     8.5 %   (0.5 %)   *

Managed care governmental

     14.9 %     13.4 %   1.5 %   *

Managed care commercial

     40.5 %     40.1 %   0.4 %   *

Indemnity, self-pay and other

     9.7 %     11.8 %   (2.1 %)   *

 

* This change is the difference between the 2009 and 2008 amounts shown

 

- 12 -


TENET HEALTHCARE CORPORATION

SELECTED STATISTICS – CONTINUING TOTAL HOSPITALS

(Unaudited)

 

     Three Months Ended March 31,      
     2009     2008     Change      

Net inpatient revenues

   $ 1,524     $ 1,478     3.1 %  

Net outpatient revenues

   $ 674     $ 627     7.5 %  

Number of general hospitals (at end of period)

     50       49     1     *

Licensed beds (at end of period)

     13,580       13,438     1.1 %  

Average licensed beds

     13,574       13,457     0.9 %  

Utilization of licensed beds

     55.6 %     56.9 %   (1.3 %)    *

Patient days

     679,657       697,274     (2.5 %)  

Adjusted patient days

     988,935       983,127     0.6 %  

Net inpatient revenue per patient day

   $ 2,242     $ 2,120     5.8 %  

Admissions

     136,766       137,107     (0.2 %)  

Adjusted patient admissions

     200,154       194,592     2.9 %  

Net inpatient revenue per admission

   $ 11,143     $ 10,780     3.4 %  

Average length of stay (days)

     5.0       5.1     (0.1   *

Surgeries

     90,867       88,015     3.2 %  

Net outpatient revenue per visit

   $ 685     $ 650     5.4 %  

Outpatient visits

     983,865       965,200     1.9 %  

Sources of net patient revenue

        

Medicare

     26.8 %     26.2 %   0.6   *

Medicaid

     8.0 %     8.5 %   (0.5 %)    *

Managed care governmental

     14.9 %     13.4 %   1.5   *

Managed care commercial

     40.5 %     40.1 %   0.4   *

Indemnity, self-pay and other

     9.8 %     11.8 %   (2.0 %)    *

 

* This change is the difference between the 2009 and 2008 amounts shown

 

- 13 -


TENET HEALTHCARE CORPORATION

CONSOLIDATED OPERATIONS DATA

Fiscal 2008 by Calendar Quarter

(Unaudited)

 

(Dollars in millions except per share amounts)    Three Months Ended     Year Ended
12/31/08
 
     3/31/08     6/30/08     9/30/08     12/31/08    

Net operating revenues

   $ 2,178     $ 2,132     $ 2,158     $ 2,195     $ 8,663  

Operating expenses:

          

Salaries, wages and benefits

     (954 )     (943 )     (952 )     (967 )     (3,816 )

Supplies

     (379 )     (381 )     (380 )     (388 )     (1,528 )

Provision for doubtful accounts

     (147 )     (153 )     (166 )     (166 )     (632 )

Other operating expenses, net

     (483 )     (493 )     (504 )     (475 )     (1,955 )

Depreciation

     (82 )     (84 )     (84 )     (85 )     (335 )

Amortization

     (8 )     (9 )     (10 )     (11 )     (38 )

Impairment of long-lived assets and goodwill, and restructuring charges

     (1 )     (2 )     (1 )     (14 )     (18 )

Litigation and investigation (costs) benefit

     (47 )     (3 )     5       4       (41 )
                                        

Operating income

     77       64       66       93       300  

Interest expense

     (104 )     (102 )     (106 )     (106 )     (418 )

Investment earnings

     5       4       12       1       22  

Net gains (losses) on sales of investments

     —         —         140       (1 )     139  
                                        

Income (loss) from continuing operations, before income taxes

     (22 )     (34 )     112       (13 )     43  

Income tax (expense) benefit

     (1 )     16       4       6       25  
                                        

Income (loss) from continuing operations, before discontinued operations

     (23 )     (18 )     116       (7 )     68  

Discontinued operations:

          

Income (loss) from operations

     5       5       (29 )     25       6  

Impairment of long-lived assets and goodwill, and restructuring charges

     (10 )     (7 )     (21 )     (55 )     (93 )

Net gains (losses) on sales of facilities

     —         8       (3 )     1       6  

Litigation settlements, net of insurance recoveries

     —         —         39       —         39  

Income tax (expense) benefit

     (2 )     (3 )     4       6       5  
                                        

Income (loss) from discontinued operations, net of tax

     (7 )     3       (10 )     (23 )     (37 )
                                        

Net income (loss)

     (30 )     (15 )     106       (30 )     31  

Less: Net income attributable to noncontrolling interests

     1       —         2       3       6  
                                        

Net income (loss) attributable to Tenet Healthcare Corporation shareholders

   $ (31 )   $ (15 )   $ 104     $ (33 )   $ 25  
                                        

Diluted earnings (loss) per common share and common equivalent share attributable to Tenet Healthcare Corporation shareholders:

          

Continuing operations

   $ (0.05 )   $ (0.04 )   $ 0.24     $ (0.02 )   $ 0.13  

Discontinued operations

     (0.01 )     0.01       (0.02 )     (0.05 )     (0.08 )
                                        
   $ (0.06 )   $ (0.03 )   $ 0.22     $ (0.07 )   $ 0.05  
                                        

Weighted average shares and dilutive securities outstanding (in thousands):

     475,066       476,308       480,789       477,126       478,606  

 

- 14 -


TENET HEALTHCARE CORPORATION

SELECTED STATISTICS – CONTINUING SAME HOSPITALS

Fiscal 2008 by Calendar Quarter

(Unaudited)

 

(Dollars in millions except per patient day, per admission and

per visit amounts)

   Three Months Ended     Year Ended
12/31/08
 
     3/31/08     6/30/08     9/30/08     12/31/08    

Net inpatient revenues

   $ 1,478     $ 1,404     $ 1,409     $ 1,443     $ 5,734  

Net outpatient revenues

   $ 627     $ 652     $ 656     $ 647     $ 2,582  

Number of general hospitals (at end of period)

     49       49       49       49       49  

Licensed beds (at end of period)

     13,438       13,435       13,421       13,452       13,452  

Average licensed beds

     13,457       13,437       13,426       13,437       13,439  

Utilization of licensed beds

     56.9 %     53.0 %     51.2 %     51.6 %     53.2 %

Patient days

     697,274       647,991       632,515       637,994       2,615,774  

Adjusted patient days

     983,127       938,401       926,055       928,794       3,776,377  

Net inpatient revenue per patient day

   $ 2,120     $ 2,167     $ 2,228     $ 2,262     $ 2,192  

Admissions

     137,107       130,740       129,865       130,663       528,375  

Adjusted patient admissions

     194,592       190,734       191,492       191,394       768,212  

Net inpatient revenue per admission

   $ 10,780     $ 10,739     $ 10,850     $ 11,044     $ 10,852  

Average length of stay (days)

     5.1       5.0       4.9       4.9       5.0  

Surgeries

     88,015       91,661       91,037       91,048       361,761  

Net outpatient revenue per visit

   $ 650     $ 683     $ 689     $ 691     $ 678  

Outpatient visits

     965,200       954,904       951,651       936,961       3,808,716  

Sources of net patient revenue

          

Medicare

     26.2 %     25.0 %     25.1 %     25.5 %     25.4 %

Medicaid

     8.5 %     8.4 %     8.6 %     8.3 %     8.5 %

Managed care governmental

     13.4 %     13.2 %     13.3 %     14.0 %     13.5 %

Managed care commercial

     40.1 %     41.8 %     41.4 %     41.8 %     41.3 %

Indemnity, self-pay and other

     11.8 %     11.6 %     11.6 %     10.4 %     11.3 %

 

- 15 -


TENET HEALTHCARE CORPORATION

SELECTED STATISTICS – CONTINUING TOTAL HOSPITALS

Fiscal 2008 by Calendar Quarter

(Unaudited)

 

(Dollars in millions except per patient day, per admission and

per visit amounts)

   Three Months Ended     Year Ended
12/31/08
 
     3/31/08     6/30/08     9/30/08     12/31/08    

Net inpatient revenues

   $ 1,478     $ 1,405     $ 1,414     $ 1,452     $ 5,749  

Net outpatient revenues

   $ 627     $ 654     $ 664     $ 654     $ 2,599  

Number of general hospitals (at end of period)

     49       50       50       50       50  

Licensed beds (at end of period)

     13,438       13,545       13,531       13,562       13,562  

Average licensed beds

     13,457       13,510       13,536       13,547       13,512  

Utilization of licensed beds

     56.9 %     52.8 %     51.0 %     51.5 %     53.0 %

Patient days

     697,274       648,604       634,755       641,594       2,622,227  

Adjusted patient days

     983,127       939,726       930,381       934,829       3,788,063  

Net inpatient revenue per patient day

   $ 2,120     $ 2,166     $ 2,228     $ 2,263     $ 2,192  

Admissions

     137,107       130,958       130,545       131,693       530,303  

Adjusted patient admissions

     194,592       191,205       192,799       193,108       771,704  

Net inpatient revenue per admission

   $ 10,780     $ 10,729     $ 10,832     $ 11,026     $ 10,841  

Average length of stay (days)

     5.1       5.0       4.9       4.9       4.9  

Surgeries

     88,015       91,771       91,407       91,470       362,663  

Net outpatient revenue per visit

   $ 650     $ 683     $ 692     $ 691     $ 679  

Outpatient visits

     965,200       957,335       959,222       946,322       3,828,079  

Sources of net patient revenue

          

Medicare

     26.2 %     24.9 %     25.0 %     25.5 %     25.4 %

Medicaid

     8.5 %     8.4 %     8.6 %     8.2 %     8.4 %

Managed care governmental

     13.4 %     13.2 %     13.3 %     14.1 %     13.5 %

Managed care commercial

     40.1 %     41.8 %     41.5 %     41.8 %     41.3 %

Indemnity, self-pay and other

     11.8 %     11.7 %     11.6 %     10.4 %     11.4 %

 

- 16 -


TENET HEALTHCARE CORPORATION

Additional Supplemental Non-GAAP Disclosures

(1) Reconciliation of Adjusted EBITDA

Adjusted EBITDA, a non-GAAP term, is defined by the Company as net income (loss) attributable to Tenet Healthcare Corporation shareholders before (1) cumulative effect of change in accounting principle, net of tax, (2) net income attributable to noncontrolling interests (3) income (loss) from discontinued operations, net of tax, (4) income tax (expense) benefit, (5) net gains (losses) on sales of investments, (6) investment earnings, (7) gain from early extinguishment of debt, (8) interest expense, (9) litigation and investigation (costs) benefit, net of insurance recoveries, (10) hurricane insurance recoveries, net of costs, (11) impairment of long-lived assets and goodwill and restructuring charges, net of insurance recoveries (12) amortization, and (13) depreciation. The Company’s Adjusted EBITDA may not be comparable to EBITDA reported by other companies.

The Company provides this information as a supplement to GAAP information to assist itself and investors in understanding the impact of various items on its financial statements, some of which are recurring or involve cash payments. The Company uses this information in its analysis of the performance of its business excluding items that it does not consider as relevant in the performance of its hospitals in continuing operations. Adjusted EBITDA is not a measure of liquidity, but is a measure of operating performance that management uses in its business as an alternative to net income (loss) attributable to Tenet Healthcare Corporation shareholders. Because Adjusted EBITDA excludes many items that are included in our financial statements, it does not provide a complete measure of our operating performance. Accordingly, investors are encouraged to use GAAP measures when evaluating the Company’s financial performance.

The reconciliation of net income (loss) attributable to Tenet Healthcare Corporation shareholders, the most comparable GAAP term, to Adjusted EBITDA, is set forth in the first table below for the three-months ended March 31, 2009 and 2008.

(2) Adjusted Free Cash Flow

Adjusted Free Cash Flow, a non-GAAP term, is defined by the Company as cash provided by (used in) operating activities less capital expenditures in continuing operations, new hospital construction expenditures, income tax refunds (payments), cash flows from discontinued operations, and payments against reserves for restructuring charges and litigation costs and settlements. The Company believes the use of Adjusted Free Cash Flow is meaningful as the use of this financial measure provides the Company and the users of its financial statements with supplemental information about the impact on the Company’s cash flows from the items specified above. The Company provides this information as a supplement to GAAP information to assist itself and investors in understanding the impact of various items on its cash flows, some of which are recurring. The Company uses this information in its analysis of its cash flows excluding items that it does not consider relevant to the liquidity of its hospitals in continuing operations. Adjusted Free Cash Flow is a measure of liquidity that management uses in its business as an alternative to net cash provided by (used in) operating activities. Because Adjusted Free Cash Flow excludes many items that are included in our financial statements, it does not provide a complete measure of our liquidity. Accordingly, investors are encouraged to use GAAP measures when evaluating the Company’s financial performance or liquidity. The reconciliation of net cash provided by (used in) operating activities, the most comparable GAAP term, to Adjusted Free Cash Flow is set forth in the second table below for the three months ended March 31, 2009 and 2008.

 

- 17 -


TENET HEALTHCARE CORPORATION

Additional Supplemental Non-GAAP Disclosures

Table #1—Reconciliation of Adjusted EBITDA to Net Income (Loss) Attributable to

Tenet Healthcare Corporation Shareholders

(Unaudited)

 

     Three Months
Ended

March 31,
 
(Dollars in millions)    2009     2008  

Net income (loss) attributable to Tenet Healthcare Corporation shareholders

   $ 178     $ (31 )

Less: Net income attributable to noncontrolling interests

     (5 )     (1 )

Loss from discontinued operations, net of tax

     (11 )     (7 )
                

Income (loss) from continuing operations

     194       (23 )

Income tax expense

     (5 )     (1 )

Investment earnings

     2       5  

Gain from early extinguishment of debt

     134       —    

Interest expense

     (110 )     (104 )
                

Operating income

     173       77  

Litigation and investigation costs

     (1 )     (47 )

Impairment of long-lived assets and goodwill and restructuring charges

     (5 )     (1 )

Amortization

     (11 )     (8 )

Depreciation

     (86 )     (82 )
                

Adjusted EBITDA

   $ 276     $ 215  

Less: Adjusted EBITDA of hospital without full calendar year of operating results

     3       (2 )
                

Same-hospital adjusted EBITDA

   $ 273     $ 217  
                

Net operating revenues

   $ 2,279     $ 2,178  

Less: Revenues of hospital without full calendar year of operating results

     22       —    
                

Same-hospital net operating revenues

   $ 2,257     $ 2,178  
                

Adjusted EBITDA as % of net operating revenues (Adjusted EBITDA margin)

     12.1 %     9.9 %

Adjusted same-hospital EBITDA as % of same-hospital net operating revenues (Adjusted same-hospital EBITDA margin)

     12.1 %     10.0 %

Additional Supplemental Non-GAAP Disclosures

Table #2—Reconciliation of Adjusted Free Cash Flow

(Unaudited)

 

(Dollars in millions)    Three Months
Ended
March 31,
 
   2009     2008  

Net cash used in operating activities

   $ (6 )   $ (133 )

Less:

    

Income tax refunds, net

     —         1  

Payments against reserves for restructuring charges and litigation costs and settlements

     (28 )     (27 )

Net cash provided by (used in) operating activities from discontinued operations

     56       (7 )
                

Adjusted net cash used in operating activities – continuing operations

     (34 )     (100 )

Purchases of property and equipment – continuing operations

     (85 )     (157 )

Construction of new and replacement hospitals

     (16 )     (29 )
                

Adjusted free cash flow – continuing operations

   $ (135 )   $ (286 )
                

 

- 18 -


TENET HEALTHCARE CORPORATION

Additional Supplemental Non-GAAP Disclosures

Table #3—Reconciliation of Outlook Adjusted EBITDA to

Outlook Net Income (Loss) Attributable to Tenet Healthcare Corporation Shareholders for

Year Ending December 31, 2009

(Unaudited)

 

(Dollars in Millions)    Low     High  

Net income (loss) attributable to Tenet Healthcare Corporation shareholders

   $ (50 )   $ 80  

Less:

    

Net income attributable to noncontrolling interests

     (5 )     (10 )

Income (loss) from discontinued operations, net of tax

     (10 )     10  
                

Income (loss) from continuing operations

     (35 )     80  

Income tax expense

     (15 )     (25 )
                

Income (loss) from continuing operations, before income taxes

     (20 )     105  

Gains (losses) on sales of investments

     (20 )     20  

Interest expense, net

     (460 )     (445 )

Gain from early extinguishment of debt

     134       134  
                

Operating income

     326       396  

Litigation and investigation costs

     (24 )     (4 )

Impairment of long-lived assets and goodwill, and restructuring charges

     (10 )     (5 )

Depreciation and amortization

     (400 )     (420 )
                

Adjusted EBITDA

   $ 760     $ 825  
                

Net operating revenues

   $ 9,000     $ 9,200  

Adjusted EBITDA as % of net operating revenues (Adjusted EBITDA margin)

     8.4 %     9.0 %

Table #4—Reconciliation of Outlook Adjusted Free Cash Flow

for the Year Ending December 31, 2009

(Unaudited)

 

(Dollars in millions)    Low     High  

Net cash provided by operating activities

   $ 55     $ 180  

Less:

    

Income tax refunds, net

     15       25  

Payments against reserves for restructuring charges and litigation costs

     (190 )     (170 )

Net cash provided by (used in) operating activities from discontinued operations

     (10 )     10  
                

Adjusted net cash provided by operating activities – continuing operations

     240       315  

Purchases of property and equipment – continuing operations

     (320 )     (360 )

Construction of new and replacement hospitals

     (80 )     (90 )
                

Adjusted Free Cash Flow – continuing operations

   $ (160 )   $ (135 )
                

 

- 19 -

GRAPHIC 3 g81869ex99p1a.jpg GRAPHIC begin 644 g81869ex99p1a.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`/@&"`P$1``(1`0,1`?_$`-4```("`P$!``,````` M```````*"`D&!PL%`P$"!`$!``(#`0$!``````````````8'`P0%"`(!$``` M!@(!`P("!@4&!Q$!```!`@,$!08'"``1$@D3%"$5,4$B(Q8*=K87-S@R0C,D M-E=18334EQA8@6*R0V-S-65UM=5WMWB8&3E9$0`!`@0#!`8%!@H'!`L!```! M`@,`$00%(3$205$3!F%Q@;$B,I&AO#/2K%3:MH^NNI"#3DQ40 M$5/5,\`I3!VBF;Z>=>ULVAPDW1YQN1$@E,YCI5(R]';&G5KK4R%(A*L,23EV M8=\+X[&Y^V\DK!9*%F^[7"N2L8!"RM&8':5:';E7:D>,3^SK(H-91HNU6(JB ML=9R50A@,!QY9%LMUE0VFIM[:%(.2SXCN.*LND2$1>KJ:XJ+=0I04-F0]6?K MAG?%ISJ8RQRHH,L'$(.(0<0@XA!Q"#B$'$(.(0<0@XA!Q"#B$'$(.(0 M<0@XA!Q"#B$'$(.(0<0@XA!Q"#B$'$(.(0<0@XA!Q"#B$'$(.(0<0@XA!Q"# MB$'$(.(0<0@XA!Q"#B$'$(.(0<0@XA"Q_D\_BSN_Z&4?]7QY:W*G\F;_`'B^ M^(C>/OJO9'=#&>*OW7XW_0*G_J]'6MRI_)F_WB^^(C>/OJO9'=#&>*OW7XW_0* MG_J]'7%3:7:Q5; M=%)!X*M3(F!-0"9!2].,Y+(($],H@=\NW,E,E10R&*0&6L2693D)G$)G[.>V M*]_`IY.(W$6P6Y.PV_FTF0+&UD<'4YC"JY$N%NR-0BA'U+&E'%U*R= MAM<@D4$F[&)9@5%(W4_HH`8Y9)\1.5%5EMH;;RY2-I(J%$Z$I0E"`C%2U8!* M1M*CB=YCF\LW?A53[]R>406Q+4223/(#,G#(8#H$X87LD_YE_)4S44PN6.\2 MFJ\R!OE%SR=!DO.[F1()<2^A,)T-FY0@\*,WB)043;*OFLXCW=?F$ZS#7"])QRJ4C\I?V-8&47'(*(N9EX10A%4$4'#A M*=\FPTP)==VF0U%*)X3"<5*,PD2P)(!C]\OB;6E-.PGB7%W M!".LR!/1/`#,GH!,>/B_Q.7+.-.C;KY1MG]@-E,TVAJG+V;&./LS7W!.LN+G MC]!-4].Q]CK"LY1TIQ*`$PMU)>5<.UGYT_5`B8#T'[J^^6.4J2FI:!!D MEQ;2'7W`/G+6Z%RU9Z4@`93,&K*NI;#EW===?(Q2E:D-IZ`E)$Y93.[(L***J/)QR=SC;N9ZE/+_`#724CCSN#3G"0G4KZ"@!X5' MYBD:HVAY6G23,M+STSS*5"923C@02<">GRS?U71 M"J6KE[Z@3F,-:%<79DVLTU\GVWUIC*:I;,H7#7B MU6A@#B*HA7CV?GD<33];BXPJK>B0YSG;0[YDHLO'-!(F[,X*FDMN\G\P0_A['D26^^2;9C'!,U94KV.'MMD+B\?+5<)9RJF[5)"K%8"\F_ZN9LU:*JH`H^4334, M0!,(7%>^7>4K19ZFZIM=([P&5+"0D#5++'&0VDR.$XA%!<[Q65K5(:MY(<6$ MSGEV88[);XZ..H^M=KUBH$Q3KEL_L)M7-3=@_$"U[V)L4!8+%%=T5'1IH&N! M7J]7VL56O58&=%;'!PH5PX4,*H@(`'F&]75F[5*7V*2FHVTITZ&4E*3B3-4R M9JQE/#`#"+6HJ1=(V4+>=>43.:R"1T#`2'IZXU]N'IG>]HWM9EJ+NWMKJ5(5 MB#EHA-GKO<*K"5FQN9)VV=H3-Q@K#4IQ>9D8L6WI("B[:`""AR_2( LE\I M[0E:*B@HJQ*U`S>2HJ3(2DDA0D#F9@XQBKJ!RL4E3=0\R4C)!`!ZQ*9["(39 MQG4O-IFGR;YO\=F+_)IL!-1.OMH=%R=L(\M4DE6:MCL$(E[&3\A7&RRJJ]VE MB3:+!O!)/?O)1)P`N"-6RSA.\*I[D*@Y4I^9JNU4R5U*/LV0D:E+Q!`5]`2) M*Y>66$R!$":1S!47ARULU;I2TKQ+F9!.&,M^,I3SGC(3B[+R%;H7[P1Z,PE- M+L-E;=/;3/5SM(8RR#LN\B9M:I,XJO5\ESM2D+7VD07\$4D/;&BH95=8[B8F M`]9RHW*L7D"Y:L5/\0N8%/FF9H;-3-IXB&`1J)4=*9F?C5CJ5(22G``RB176 MX.,I`3,MPV"9Q.,DB6$IXRD.B*Y8C5C=;Q%>7+1#$E5V\V#RAI/M1F).LU]M;+Y.R[!\F MTCG@6/%^2*K)/7U4^?1!'K1XSE(]LS^8,Q,HD1!9!=,LH7=[#SIR9<*UZBIF M;]2,:CI0`<_"XA0`5(R(*23(YS!$Z=AMYURW/+D)DGK2H3E/$2,L M0=AAKS;+*.R&,Z]&/-?\.M,EG=(20V"7576DG=7,C[8&`M:7'NF,O8!=$45. M)T53%1%$`.F;O#E/6:DM=6Z4W)\M2EI&6K?XC,#MB9UKU6RD&E;U[SN[,S"] M63]G=ELCV`&F1\D7>/69RK46.BW*;@@>BK7H@D2O7EDTEIM5*WJI6FR"/,9+)[3/U81%WJNK=7)Y:ACEE+L$O7%PFX&6=A*N^9Q*\([D6A7<30X^QOWL>WCIAPR_K3PJ"WO1(=- M(O8'K$A0G,`XK*0#,3P$Q+;NCNUS]4ZHTM$"5)'B(V M;@#OW_[8K7Q_G_>K$.0X/%H6.^H6FRV*+K\?32FIMO+U;3*K-#?!2DJ*FSIP`GLPGUB.2U57)AT, MS5K40)*$\^OY###.6JN8 MQWLL\*((I&4$$B=3J'!,ASA6E'1/7"K%+2CQ*.W8-Y.X#/U8Q*'GT4S)=>.` M'I.X=<0OPW%YHW-AS9:RU<[7BG#,XXRO MVKY1$P(H-E6B2P%%8I4TS$`_=KET%C7[G1(0]7)'C<<`4`=R$'PB6TF3GW1_7F#QX4Z8K[R2PA<\BXRR,P0.ZA7@Y)N\M! MR[Y(@J$9S02LT_DF?O5"@7W;58AT3#WF(J`=@_E%S*^AP(N#;3M*<"-"`0-X MD`#+<1CT1^OVMM22JG4M#HR\1(/7,SB'&H&]64Z%E%M@O9"6D9N)=V%2E%G[ M0H0]IH5N1?'BT6,U+'[5)B!<290;*J.3'6;&,14JID0,7G M*^L8E+'ZE'LCN@R=DNGX@HU@R)>Y0L36JXS%T\7`OJN7*ISE19QL2< MD[4(BW1*("=4X`(@'40_*2E?K:A--3C4ZHX?*3N`S)@\\VPV77#)`B!&'7N: MMWT)#)ERMELPKKVK(OXVBX[QU*GK]OO39BNHT=S-MOC5,)A.+*X3,AZ,>=NF MLJFH!1`A`46D=,DHRGMF9R$M\AS6#47&;SBE-TL M_"E)D5=).?H_VY1E'QWXWL,"[7Q9;\DXRO[5NHM#6`F2+U.Q[N2(03(DL+:8 MG)!X=LY4`"J+-545T^O>'?V^F;#2Z($ZV[NYEP1EP^$]E)N2L%7:64],G)"SN?F5CQ_,$K)*)R,\2D]>T?)B(8``Q1*!P,42"7N`X"`E$HAU[@-]';T M^/7E<1)HK.F]FKML[FB5UWU@M#.FUNL,GLADO.OM&\O)$CF+Q"*=,,;1CDP, ME5EY%V5!.15[@.8#*H@5-,%%96W:J>TT*;G=D%QU9`;:R$R)@K.>0GI[#B9# MD*JW*NH-)1JTI2/$O/H\(^7\#BF7O'#.KPKVV8FV`S2ZRLQ04D4EKW>W;Y"T M2")!5%J66C21#VNNW9@$$5>Y9!,X@!R`7JW)09(A\"9YD7]D3GY56KUNT31"_BNNVQ% M59NC7K(Z*4IYAH^>HF:E66[G2#H2@=11,P^GO\PA!W2[!+.'J,0$M8"%.Z:FEFD6LZ53+W(-$O32!-14QEPF MU32TG+5&VM;2'[H[/%8FE,I3DGHF`-I,S,#".$TZ]='U!*U-TB/HX$SRF>F7 M9&3YP\=[FN5*3N>N.5,PPU_KK-Q+(P4MD*=DTK2#-,7"S%E)IKM).,G'!"&] MN85%6ZJW0AB$`WJ%Q6_F8.O!BZ,L*IE&4P@#3/:1B"-^1V]$?=1:RA!3S%3LTMV<:ITA#4DD`98I!,NV-RV.+=HTK<)4N9Q. M>!,;RS5F2EX&QY-Y(O3PZ$1$D(BU9-@(>3G9AUW%C8*(04.0KB1D%2B!0$0( MF0IU%!*F0Y@Y]!0OW&I32TX\:MNP#:3T#\@QC9J*ANF:+KI\(]9W"(78;@\T M;D0@9[&.>PFHKT\=]2D,'RI M293&\G/NWQ],Q^/"IRM>>RN"KGD7&>1XY!1U"K#DFZR<%-/$2BH5C,#*S+Z2 M8&>J%`H.VRY!1./>=-4H"7GY0\S/(<"+@VT[2DX^!((&\2`!EN(QWB#]K0I. MJF4M#HR\1(/7,^N(A:;[V9/I^3FF"MCI:0FXR1GU*:UL5G,7\54:XI/3QB,5 M/R9@*>6A7JZKY)8(:;,CA.(5R4R MTY<'5N)2I:&P4DB_X5R]1;`V1>P-TQ??JI-- M'!`50;=O>735[%0V9.-O(4#TI4".Z,-2@ M.4[C:O*I"@>T$1S6/RV$V_@O+MK8R9K*`C8J5G.LRI?4,4'4<7#EJGBD6`/Z M4"RE=:J]!^'>F`_5SU-\4FTN4$(4X ML-H$UJ(`&\G*+?4H)25*R`G',ZU9V8V8W+\TMGWCQ;K(\W,R57K#D++M#P>Y MR!#X_8UC'E>9&QSBA\%GL958YDTQ?$V*+6;MRD$[F5$%@#O%0W/55WM5JL?( MB.7ZNK%#2J2AM;N@K*EJ.MP:4XGB%*@3L3ANBHZ.KJ[AS`;BRR:AX%2@C4$R M2/"G$_1!';#8?_V+>;+_`/APX_\`F-BO_P`+Y3G_`-8Y#_\`Z`?^F<_'$V_B MG,'_`"[_`!4QBM[WB\R61Z1<<>6SP4FE*M?*K8*;98UQN)BI1"0@+/$NX288 MK$&+`#I.H]\HF8/K`W,U/R_R12U"*EGF&3S:TJ2?=G,"D@@Y[Q&-RXWYUM32 M[=-"DD'[5.1$C"SFD'BS\U^DNU6$]D\;Z8VTDIC.X-#246_R5A\D?8Z%-]T! M=ZG.+MNK#64W//)H36$%3[*F7MZ74@`JZ#/2ZGK$4W<&'; M#>R6<`VL+1TI)G+T328ZG-,,.-R+':]V]>$JRW5C6 M55:K9EG)J`:(-4T4$HV2A'C:.DBH)B8%(^2:+]0]P)"^QK.Y;:JA=Y?0LOBA M0FE>U8E1X0!ZP1-,]BDJ&R*5KD53%0FXJ2&R^HNHED/&2/1@>D$';'4FT?VA MK6Y^IF!]FZOZ"37+./H>=F(Q`W<6OW)L4\1>JP?[9S`I6KE'/F/VAZF!`#?6 M'/)%_M+MBO-1:79S9<(!^DG-"OTDD'MBXK=6(N%$W6(R6D$C<62\R")U00/*.(A@H>'K[500$`D+)-';Q[8.GVG#D M@?7S!:+:_>+FQ:Z;]<^ZE`Z)G$]21,GH$9*RJ;HJ1RK<\C:">N60[3A%2?Y? M/7RXTW42U[?YH146V)\B&3K%M'DB3>HJ)R*=7L\C(K8SA1]8`4)&_)G[B8;) MA]E,DWV=`[.3/XDW)A^](LE#_++8T&$`9:D@:SUS`2?8CA\L4KC="JNJ/O54 MLN*ZCY1U2Q'7%,_YOO#=Z=SNG.>DH]^^Q:Q@G9!!)92.KMTG)&O6J`1D MEB%])DI;8B->D;&,8/5/&&('VNT#3CX*UU.ENNMQ(%65-N`;5)`4DRWZ21/V MHX//-.X5,5(!+("DGH)D1Z/J9=+ M0\1BZ+GF*@F+>(KJ[:PNSI,(#**S!LFB]C'BB191T7UV*BAUC-4.!S]\.Z^W M53UYLZ%/6MQ16I*1-;))FKPC$MSQ"AY1@H"4ST>7N9:>I910UJ@BK2`D$Y+` MP&.Q6\'/,9R#'.6=?,0YRF,03^4:3^27I,3IKF;-QZI M7H*KPNB7M(>N0\;!1;5/,=5*1O'Q+-%BS1*`-1#HFW0*'(^[06-YU3SEQFM2 MB3]DK,F9CHHJ*]"0A--X0)#Q#9'M?ZQ>[7^PT?\`TR57_-.?'\+L'_,/\)4? M7O=P_P!-_6$5BY^U2NW7>S6^C12&J#@1,`E*A@22!*1RG*.14T=;4 M/J>#)3JV3!QB]77%WE1WA6AAFJ$-`9+8Q1XFRM%';1ZLZ5B';B-8R[E=BZ>M M!=S<:U1=K`14Q056-]'\D*]N@I!7N>X*U4I5-.!&>)&,L`9@=$2.D+QIT^\" M3P$CV;>V%_O)Y_%G=_T,H_ZOCRQ^5/Y,W^\7WQ&;Q]]5[([H8SQ5^Z_&_P"@ M5/\`U>CN5E6?>W?WBOK&)2Q^I1[([HI4\L^6I&:OE&P9%.U2Q5=B$+E/M$3& M[7MGL"KN.KZ3A,#=JIHF)0442`?YS_K](`(3KDVC2W3N7!8\:E:1T)3(GTGN MC@7M\J=33#R@3/6JJ!E48MBB MU]TLD#8W8X=G3%53J(B*AQ$1$>-:B3]FK:?DC<:?KFFTM) MIO"D`>81F/\`K%[M?[#1_P#3)5?\TYA_A=@_YA_A*C)[W/8AJ:/+*F=GE(PP*N8XB")B>G\`0`>X M1,/246NZ6:V4@I/>PXE*B0="A('&4I';/TQR:NEKJIXO<$I)`F)@Y;=D6R8/ MJ6:[KJ4?%V9"R6,LC*5:>QJ%@;N(V9F4X--B,/!VDP,)!5F>44BE0*H'N`.= M5(5!$IC_``AM>]0,7GWNAD[2ZPO3B!.H_4'* MIHW$LU;3R_(EQ)/4""8ESR2ME:$^8I(](A:/379N3U)R=,%M$)).JA800K.1 MJ\DEZ4["OH)XY2;RS%HX,B526KSE=RDLU4$GKI*'*`E4*0>6I?+2B\TB>$H! M]/B0K801D3N5@9[#$1H*PT+QU@\,X*&T2V]8W0R]CK)E#RS6&5RQW9XNU5Y^ M7[M]&K@<[=<``5&4BT4`CR,D4.O11NX336(/TE#J'*KJJ6HHW2Q4H*'1L/># MD1TC")C0R4#`C+3.4BR5AE'4S+KD. M^<.5B%=2+U10$P,":?=VD*4H``?E34OU;G&J%:G-($^A(D,N@0::;93H;$DS M)])F8H>\G^2YG(^P-:PA"^Y>Q=%:PC-.&:+%)\VOEZ!JJ/01$J8.DHAXR:H& M/_0G76^@#FY8?*=*BEMJZ]R06X29[D(_*"3OD(C=X>4[4BG3DF6&\J_)(1/: M"SCN16H2'KD-HC[.(@(N/A8MHEF.J@FUCHMHDQ9-TP!KT[$6R!2A_B#D>$K,XF.DFHKT)"$TWA`EYA'J_P"L7NU_L-'_`-,E5_S3GQ_" M[!_S#_"5'U[W-6-M,TY9MN4V>MDE1U+>XCY!Y!L;K3Y--M+- MHQFP>R*,@:8CE!6DG#/W)ONBB54YA`1^GDKMUWLU!1HI%50<")@$I4,)D@2D M_B[R:?W0*?N2_9__`&BJW]MO[R/[3?VG_P"3 M_P`EYQ>#RI^V_P#,:_*KR_0\OE]<;W$N_P"S_N].8S^EGGZHS3SB?_DOO;_Y M'2G_`'U"XGO$8WC)E9_-/=',Q_+=M#OO+YJXH41_ MJ5:SM(J"4O<`D+@R]M?M?:#M()WA?C\?CT#I\>>J_BB0GDJK&];0_P`5!^2* MCY3$[XST!?U%1T>=P$95SJ5M&W@_4^=KZZ9M1A_2[O5^:JXTLQ(_T^SJ;U/= MF)TZ?'KSR_9"@7FD+GZOWIJ?5K3.+6KM1H7@GS<)@'6E8"U8WN[MHWZAU%<]>KSQ7H'Q]-`X_0'/1?QBIW'N M5TO(\K58A2NHI6B?I4!VQ6?)3B478H.:V2!V%)[@8Z.7/,,6M!Q"#B$'$(59 M_-1Z1AF/5*F;C4^(!Q?=5Y8T;>E6J`&=R>#+](,F,NJX,4?563HES]A(D#H) M4&3J04$0#KRWOA#?_<;PY9'U?Y>L3-&X.H!(_IIFGI(2(AG.=NX]$FO;'VC) MQ]A6?H,CU$QJ'\J!O#^,\295T,NLP*MAPT[=9;PPD[7,99WBVY2Y4[S7&(** M=/1I>0'Y'H$('4$K"`!T*E\-WXQ6#@5K/,3"?LGQPW9?M$CP*/M($OT.F,') M5QXC"[:X?&WXD>R3B.Q6/Z46(^;ZTV#/2FJ'BBQE*.FEVW[RTP'+[R)/W2%/ MU-Q$[:73+]@U3F1CT&K8QC%(Z*V=(?'N$.1GD)EJW"LYPJP#3VYD\,' M)50YX6QTRF2=TP8Z]_6NHX-H9)#E0L:B-C:<5'U8;Y$1@OYAW0*`S9XRTY;% M54;M+1HLPC\A8VA8AH8RC?$%9@6M8R32XU)/N.6/9X_9(RA$PZB96`0*'Q'F MQ\-.8W*#FO16+)9N!*%DG^\4=2%'I*R4_IF,'--L346C4PGQTPU)`^B!)0'Z M./9%:'Y2KL:DD]"1')Y)N$PY;5G+QH[E#N/ M:8L1\Z$],[99KT7\/F/I!XF\VHRE&YBV27BCG!S7M:<2/EY=\+X4U"D(C//X M>0=H`IT`SN!1)_QH`,9^'[:+-07#G:I`TT;):8G\Y]P2$NH%(/0L[HZG,:E5 MM136)HXO+U.2V-IQ]L"&-*_`0U4@82KUR-:0U>K<1&P$#$,$@08Q4-#LD M8Z+C6:)?LHM&+%N1),H?`I"@'*P<<<><4\Z2IU2B23F23,D]9B5)2E"0A`D@ M"0&X#*,%S3A3%.Q6,;?AG-M%@,D8QO<6>(M-0LC474;)-#'(LBH0Z9TG;"18 M.DB+M'C91%VSHC+9MQ M5#H"=PZB^3_BE17=2+??---?X8?S`V5 M]6[=1=<-P+E*Y1U3G7\75H#(EH>N9B^:]^[42CXM^:?<&<25KQ.Q.9,CUB[, ML[AVH"NS5]%$S-3ZYY^&]'=V7+I9$)9O"05%"1)#VTB627#L(D%'!0F=0_+! MS.]1K325RBNB)`"CB4=NU.\'$9C='1#;N$':"#IJNBY:N44W#9RW4(L@X06( M51%=!9,QDU454S`8IBB)3%$!`>G/-!!29'`B+2!!$QE"MN^W\9>7?^W:9^I= M3Y;?+O\`(F/95]=40VY?S!SK'U1#23?_`"=#_F4O^`7E2*\QZXF(RC[<_(_8 M5^VFE!K6_EQGISN!I"Y?Q[..!5'X%AV#:FORJ!U`0](D>CU#_$'+9M".+RXA MMOS*86.TZAWQ#ZTZ+FI2L@M)[,(9_(H"'TARILL#$PC]N(0<0@XA"Q_D\_BSN_Z&4?]7QY:W*G\F;_`'B^^(C> M/OJO9'=#&>*OW7XW_0*G_J]'H)N6RQ#`(@8BJ* MA3`(?`0'E5*2I"BA6"@9'K$2X$*`(R,?V\^8_8.(0<0C4>3\]8_T9QH)#:6]9;1*WUBPK9[6T=B*:.5,JM7F-L5,B":2;F4KEL623[$B6R,;E] M4'ABE*0)%MT(1-82I*J)`8(NSP+@2" M4BI>UPV/U`#(+%$"SXIME_HYG2XR:MZ_K_)IDR'K).&*Q@*HY@Y=$HJM%3`!NA3IG^\ M2/RLKQ:7;35<%1U,J$T*WCIZ1D?3MB4T58FL:UC!8P(W'\1V10YL7+?ACR!V MN?GA,5I"9SHLVZ,J/0"0S)6HOR*"(AT]).-3`P?5VARP[6CB\MH;;S53K':= M0[XC=4K1="I60<2>S"&@BF*8H&*(&*8`,4Q1`2F*(=0$!#X"`ARIHF$?GB$' M$(.(15#YS'39GXD]ZE72Z;=,^%G+0AU3`0IG3^RUUBR;E$?I5=/'":1`^DQS M@`?$>3'X?I*N!B>//T)43ZHXO,1`LE3/]G\HA6S\HBLD7;W;1N90H+K:W MU59)(1^VHDWR>_;I.V+]LNS>-5R`H@Y:.DCH.& MZQ!^!TED3B4P#\!`>>6$J*5!23)0,Q%M$`B1R,S2=L4O5-5%@O)X>"FEZD3R4@Y=A'A M/;'2*T#\ANNGD5PK#Y;P9:60S";-FED?%4I(,@R'BBSG1(+VOVR&3.5S[4K@ M3>QDTD_82B``J@JBN"#HF=#@!T.)V*2>].:3@8M>V72E MNM.'Z97B^I&1JE8:/;H5R`"A*5NTQ+ MN%F6)^H&[?)9]"4:]2F*E)%2'^6C\/7-2BDY\Y-)1("KI]2?S'D[/T7`4G>F>^* M<:4]R_>\9S9*]PGOAO!NIY99$JTCC$[]+2_2)=^V<(IDP MGC!TC)9&R!$,I%(CI@3(]Z6*J0_:FJF;WCL%!R5NA:VUAQLD+ M2001F",01U1)E)"DE*A-)$C'+HMD1;O"%YGDSQ99,E4P#G%E88`I3&!:YZMY M/(IWQW>0#$>+KXLLCJ.4Z=P%EX\W\Y/X>M65L\_Z&_'F`M#-XK5;[W=FL-3F M7CQ%P#TBI5V14"HJ"L!BR"CL*ZWEZKOC*B54;S25HE/P.:AKG/"2@`1*4C.8 ME'.>KTL7%FA6``\A1!G\Y,L)2W=/9$Z.1^.C'.J_-#Z*X9U7V6Q=G+#L3&4V M&VN@\CS60:!%)(M(2.R+0WM9&?N4%&($30BF5X87)%1ZV2*"/S)JLX*`&D@;(JSG&VT]%5HJ6`$I?"B MI(RU"4R-TYX](Z8>/\>#:ZL]"M,&N10=!>&^KN"T;*5_WA()R1,:UPJB4B"O MWOS%(@%*X[_M^L!NOQZ\H'F8L*YBKC32]W-6[IEE+6K+HW=$6):PX+;3AW]9 MP43_`*(BB;>]R@YW(S`H@H50B=CJC8YBB`@59K4:J@X3'H(]!253$!_QARP> M7@18V`<]*OK*B.7$SKW);QW"&F&P@+9N(#U`4$A`0^("`IEZ"`\J-7F/7$Q& M4??GY'[%`?E?PH_@\D5_-\>R46K=[BF55LKHA#&286V!;JI1GNS`7M2).5XA M$T1$?M'8'#Z1*`V/R=7IB5O%O8M=42$&P)(&*E'!*!M*CL`])V1@J*ENF1 MJ6?$<@,R=P$9W2Y2PS=2KDQ;*X6H663AV+ZBD.4PI4^C)J@40$4U!KA%0(*^L M8E3'ZE'LCNBG'RT85?HSM+SU$LC+1#V-1H-T613$P,)!JY=/*K(NQ#KVH2*+ MQPS$X@!2J(HD$>JA>LWY-KTEMRW+/C!UIZ1DH#JD#VG='"O=.=2:E(\)$C\G MIRC<7CIW)KEFIL!@/)$VWB+S5&R<-1I.69[&ZT^JXTJ9TZS-8&:5;3+Z)SGL,Y[(SVJO0ML4SID MZ,!/:-W6(MKY#8[<:LR[F7'^$*HXMV0)M..:@/MHF);%]Y8;1+*="LX&L0J0 M^\F9A^N;6?6 ME^@_%8D@[:#%$1:BH4R385#"0I3>F))9S55/T%(S247V3"]0.G#!,I)$L@9X M[_3''M#**AY;S_B<3+/'.>,7ZF,BW1,8QDT&Z"8F,8PE21112+U$QA'M(FFF M0OQ'X``!RNL2=Y,2;+JA4Q.3CG6\J,PT?-'D4YVM0?M9)FX2=,73%;+!%D7C M5T@7]"@0L4PWDR)S)BRAY0A2D28W M6M1LV+0BWN?EKYPB!96(47]-(55H>436:J&$A1$Z0_`/HYDKJ5=#6.4CGF;6 M1/>-A[1(]L?##P?92\G)0GU;QV&-5;=8(IV=\,6N)L;5LC-UN%F;)3+*)$RO MJY/1T M,P=_;&&NIFZFG4E7F`)!W'\6^*K?#^$PKDK+[E$K@(`:!7`D>G=[4)A6>74A MRJ#T[1<`Q*^[?K[>[DOYUT"D8!EQ.(J75+'URCC6+5QEGYND>F>'RQY7E;PH M_KN483-;!FHK6OXG MODVUC,NU*.;0K(LFNFW"_P`)'(D;QLK$KJB0CN>;LTR)OVO45SG(+@@&(K`Y,",?!5F%3$73QPZHJ6Z9&I>*CDD9D[@(QK]H MV?/[@&?[G_QG^\N+_>?_`'5_]"_RO^L_\G_WO,WNMM_U)_7Z?U9_5_M,_P"K MG'SQ:G]E_=S\P\WT(9F?AU$(4 M93ZA.4]D5$^&W!&SE3W"+8O&QNMIUD[-,7CBQKW:A62D;FQE$LN)1F*XG.,; MO(6[6.AQ+-@%B/%G:*)RS1\5\5/VXG^\(::<\7"TO63AJ50B3(81W[O(49%6!&=66,X!RCV'0 M(4J?8H81-T\VW9-G35RL:JA5%I&+P0%ZL9B2"1+*1SSBSZ,UI9_SX;#\SY"2 MF6SS8SA=3S+4KS$Y-UOSTRRCES1W7#1^-=RBE^E<>M-F+MDFQXE):2IUXF1U M*WB/(\]'QB[$62D^E!1R34@>L5=P+$%>ZS>1W^2*2Z4ZJ1FX55_(&@++"$)< MTXZ-3B`3.>C6J>4AJE$5O[=^>I'0\NG:MP\Q3Q"HIGAJDE1W:M(ZS*%Z_$3@ M7/M7W6J=@\=6[FFN1]A8JE7-T[HUDHVYD?3[-C("Q1+I&VY];]7Z/#M(<[@[ M`R:A95F[*^*W%N8RG0AK*YTN-M>L*V^9J"N:MA<3XTKIBI+F.DI"7UDG/YI$ MISPB+V.FJD7!*K544ZZH).!#LBG"/:Q:)F=Q M._=B@5ZC(D9,A>@3VCM!Y\1EWPXJ><*2K=>Y=IS54`EQFU+2A!W24M20'!C( MIF99I*8XW,[5E>90BY.AFHQX:@"I0WS"024[YR$\B#"%52QOE7'VP49#:(;" M3>>F\4T:Y1:/40%RB!GK$AO@*RA>AA]$/ M55'4VTKYBIDTU)\Y-2JG4@'V@XM)Z#@>@16K;3S54$VUTNO;"T'`KT%((]8A M@3'N`/.9DZM^IO!O=NQK)@!!H`W(\!B';7+F6WE<'XR"*$!@3"C@R9S-^H'6 MEYTA4@^T=%4`$HUQ4W+X?TCLK!;J"KN4_#-RG;;U;,7G?4E':(D[5+S$\C_W M&IJ&:66,DNJ5+J0CO/IAG#PUP/C$K&`;17_&W=8[([.(M9V6=[W9F%JB\_VG M(Z1%05F,U1V1JU3LB,GKH17&/3<1C*+(3U@8I@'K"-4<\.NJ;34-/LK5:.*5-+!1YY`. M(`4H&1\)!EIU:@3.*UYU11FL;4A:16:)+3(^7'2HD`C>)9REA*&ZO%["Z[5O M0#5BOZIW)AD3!D)BV+BJI?H^*G((MTE6#M\VO5H>PEFC(6QP\O.7Y.4ZKN)_`\Q*S#JGW)_.5ZIS5?8_A&^1N:*6K:4TM5G*P4K!3@\`-20%*!.I!29@2!2)D3BNN=T4I=94%@5H M204R.*"3(S`(P4#@3,SPRAH?Q1P>O-9\>.JE>U:NL=D?#4+C%E&0]^CHF=@B M7*T,Y&11R39'<):(F!LL1(R^1R2J[AL_9MW*"IQ(8@=`Y4O.#ES=YEK';NV6 MJY3LR@D'2D@:$S22D@(T@$$@Q,;*FE1:V$T:@M@(P5(B9^<9$`@E4YS$XL*Y M&HZD*8_F9JK8K?F/Q.P^)LF(XKV"?9WR8PQ1:THO(\K,0LXY)BM:#G8EKB^D M7ZU.'4=<&<:B1%K'.%%%'91,F+:O&E32IF M;O&ACG9+($$R38$S+K[M[AK&=!OKALB1$DU*4?+Y("TU%X_.7U71&J+AN"AC M>B@D3M3+%ZFU3G'5;J[^RCAU%( MEYT#SH=0E)Z9*D1^&`BC+9&@U_)OD2PCG3\PKG'&>L\4A%Q"^M6CF.JSF+*5 M+?UEM/5+4TVH*TYH:4L.$Z<&_#(&:'$,ID.&RD*4) M3^]R`I>'EB M53PW2E"UF1\9)?CR[?M)V*QK^/\`\33?XV^:5S/'S/\`$OOEOF_N?;X8]+U/ M==W9Z/W79V^E]CMY:5+5GW=OW6E=]VT#1)3,M,L/[WO[8B;K/VBN*ZGBS,YA M>?\`1B];&A?(#!TJMQKTNM5X0;0L:2/L$Y*9-K]@?QX,T?8JS35.M(D^8BU[ M?5$S5LJ)^OJ$`_=ROJK_`.MN/K4GWILE1F`&U)!GC+Q9;L3T1(VOXFEL`\)6 M&9U`]N&<3&T$SMQXYN:Q-:RY?/*^A*B3^M)Q#J20;/UV)3_R# M+)D.(?2`N<\)2SGA+.,55P.`KWF7!EC^&_=+&%>HDNY>G0`PD!)$3DY'[P]='J.;+*&;.# MDVI"@=Q64$]P'691TJ)%(A^2UE==+-04#^CJ'Y8F%F)7:XTK[3!++!Z<`K#H M@I,9(?7(9UK-F7=`Y]M&03,T8JQ2;`B9,RBHF,H)P,7H`=>+0BSZ-5P-1Q-6 M2`F1'63.><;S_OLY4W#TRS5.<^S"%V\W8TF#97O9LU[#XR)E$TVH:Y)R==S? MZJ;\S=`R":'R[#:D7\K3CA1!G[4QFOM03](1)T$;,H*M'N;?N%,][II\,E-9 M=KLYSSGC//&(M4,JXRO>'4<:>."_^C+JEA%Q&KC#=6MXTQM'(RV!LB8P-'5\ M]?C(;#U^5!#]H>J*_8`K^N"O9[?T?ZQ[CL]'[WLY'Z/WKWIOW+5[UJ& MF6<_PSGA+/".D]PN$KCRX4L9[H5LS;CW`$),.9/!.>XV[5=TY]:.K=FJ&3H& MX1`**=R#(LD[HB,+-@@(E*18ZC-<1Z=Q#&ZF&W*"IN+C>BX4Y;=`Q4E392>F M07,=6(B'5#5,E4Z9P*1N(4"/ZLCZHD;B*#\BLQ"Q[2J7'-54IBB"964I9FU_ M/'M`BL8B-3L=C4;%(/4@-41`0#[/.76NO=0S+#AF+,EMRUM:]24-7U- M\?MSJ`Q]>Z)]['L\:R&#,FL,P2QX''#VL.FMGG$F MSQXXB&ZZJ"3&39M(]H^>N9!E*F04;IIHJF.N4@=ANO3D<72&G5XCLI3[2+>J+24' M$3D!!RU1*X0$Z5VBLDP]7BX]!1R*/1,[DW:[[?;+B?H(V;/< M-,%D0F<4X2KEPE&L^!3I_>Y6M=':6I_&U(5>WUD2.P9'#^D62Z?&)-.V]IW@ M\NM\6N.3CJDB7[M*RD%6XRGN!CKK14K1KN2]%.,TH!,_:(G(=LHJ*V7@L:M- MAK(.";I6Y>I3%BCWM9+5H^QL6M3E%O9)EAHWV=>!N^:LY4G>P7AQ>IJ)'3`@ M^H`AR:6IRK5;$?Q!M:7DI(5J*25#'$S5AAF%2]$<2K2R*H^[*!;)PE/#H&'H ME.+B\8T4:U*59WM=F[(N1LLRM?M!,?Q4S4LCP.+ZHJ-1E!L!HMVM482O3UV+ M5A=>HM(&3=BAZH(M^[N.,(JJCBH6FST[35&%)UD*07%>(2GXB0G5++"B(T^/QQM12\9*V+$T13\S8B?V&1;N<>R-@ MFJ/8H.8;&3(]D*G8;76V%:7(_3`AW**2[MJ"HB!C)./6#G5YD%H?J^%6*6Q6 MA(\8`4"-@4E*BK#89`RWB4:EL-:VSK8"7&"3X22"#O!(EWCMG$H=B+;N#D;& M]JK:&)(C7>@+P$D?(^1K+?8S(D\RJ";10]@1@:SBUM89@WJQH*E6,FBLL9`3 M`3TA'U"\BV,V2EJD.EY554A0T(2@H!5\V:G-(SZ93WY1N52ZYUI2-`::EXE$ MA1EMD$S,;)T$@]=JYB21B,`79/(AFLVG^T.W.(:7KTO*6=1@BH@9Q#3L=&R$ M?#(L#`2/3*0Z`)E/T445]8XZO,;ES=K0NXM\*:?`F84`F>\$@F>>WH`E&:V) MI4,%-,K7CXC(@D]1V;HD!L(GAQ7$%S2SVM%ML7*1Y4[$XDP=&]`3KIECUHLL M>DO*C.I/Q3,R!F0[KW`%](HF^'.;;37"M;-NF:N?AEZYSPE+.>$LXV:K@-R/`KO2'A&,A4]1ZAE`,T:J"ZI#: M%DG:)Q`J;ANX;JJ&#J"!!^'+9HJFM=;E7TY:N(>^TPA4 MZ=P+3LP4#W2B6V+J[Y'9Z)8M&%]S52:@HBD",M:V.1I`[9AVAV*,&C.GV2W+ MD!+^05(A>OU"'T\XU6[RPVLJ4VPX_N24#'IFI*8WF4750`"G$M[SJ_$3$Z]3 MJCK74 GRAPHIC 4 g81869ex99p1b.jpg GRAPHIC begin 644 g81869ex99p1b.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`-`!X`P$1``(1`0,1`?_$`+P```$%`0`"`P`````` M``````D`!@<("@(!`P0%"P$``04!`0$`````````````!@`#!`4'`@$($``` M!@$"!`,%!`8(!P`````!`@,$!08'$0@`(1(),1,402(5%@I183(8<8'!4A!HD-"8V)[<9$0`!`@0$`P4%`@L%"0`````!`@,`$00&(3$2!4%1 M!V&!(A,4<9&AP3*Q0O#14F)RDB,S%187X:+"0S7Q@K)C0LO!D#)\:54CC%F&&)+_`&U@[*F(IM)YRS=(5JL. M#G]TQ7[]!4@ZZIB/+@WV3IW+TM[9?W[@ M4Z0<$XXCF>$`SF?J>MT.X&UJT?8-V\YB^2)U3(,U;6XMV1Y[S!T!)5_6L7L& M,7#B)A`3`YEN@FH`)A\>-''1G9K?I_,N3=&T$B92DI!(XC'49^[V0%.=2]TW M%8;M^@<6"9:BDD`G**HEU@(<_L&D_AO1VA/BJ*E[AX=7^%`^V+%NKZEU7A++ M#7MT_-42[#4KZJM(Y73[+>Q%4`]XT9*1,(9-;7F"9U87'K94A@'4-06$/O'A MIZHZ0*5Y;;.X:?RTK.'9OJ-,7I@MDO9QLG MW'1C,06=*8MS0]QO:721`T4!HC8ECQB[LQ>92`T*`C]W#"MMZ55:2FGW"O8= M4/#YB=2`?SI,B8_WA$M-?U`ID^;4T[+R0/H3IFH<@0Y@>.7")IK_`'C6E$,U M9;XMD^[K98MYJ2+NZ63&[O+N&FQQ$Q5'KC)6+2S81,<0P:@N[8))E*.IC!H( M\4579[2D^=LFX4]:V9C3,-J_55F>\184]R/)$MWIG:4RS`*L?E\8*KB+.>', M\4UCD'"^3:5E*ER(#Z:RT>?86&,\S3K%LY5CUESL7I`'WD%P36*/B0/#@1?V MVJH7#3U#*FEC@??AS[H(J;<*6J:#E,O6R-5`6E5"J`10 M$`+U?0'32S+;IJ)G>KFJ&_4K7@@D$('/$XJ]N`R$HR&_+DW0GT>S-K"3@5`' M&*B=GKL%.]SD.MNDWU%LF+-N,6Y>2,'CV:/(4BZ91^%K'6E;'Y7"I:4(4#)4L09E7L^(]T;5,,VC8%MZI49CS!=_P!JV*Z3%(I(LH*CW[&, M&U4(D70BSY9K.E=RCLY>9W#A1590>9C#Q\[5J+HW.H-1NZ*ITDS25!PR]DQ( M#L&$;)0G8MO9#-`NG;2!C+3C[>/?$ODW.[:USE3)N%P>LH80(0B66J*=0YE# M%*0A2)SXB8QU!````$1$0`/'B,O:]W#>L4[Z4#,^6J7O(AU=?M+RM"'VRYRU M_B,2K+3T+78QU.6"9B8"#9I@LZF9F491<4T1$I1\YU(R"Z#9NF.O(1-TZ<]> M?$!NG=>>T!*W')8:)Y?HB0[XFH\BF8/G*2A,YXJ/VF&%3\[8.R')*0F/\R8K MOOK80TP]4IP][+8:S68-Y+VR:K]=K35/22E+-)1T7!-4U5"H)E?O MY1=&/13564*F`'.7J.8"\]=.&2S6%T"B05O$\"J8[0!$U[R7&2[4*26,R3*7 M?/#WQ0Y[@39.^M,KN(Q%><>8-N\&^8EN&8,"Y#IU-B9`IA]0C#9X MM)(I1_NIUBLX,41.BJ4P=06ZG-Z6VFE?0^\LXR6DE7=FK"8R[,HI6F:$DU+3 MK2*?[I20!R((^G.>4NV+LT;*&.,DMUWF.,AT;(C5D)47SVD6VOVENU5$1*)' M2D#(OR-U!$HZ`80\.*BLH7Z-T/.T[B'%&4U)4G[93BT8J&GFOV"VUI!X&

'&4"'P[T^7KU9!!_+$^^']9;K6*9#KV.XV*NU*N-12* MZGK/-Q\##MC.52H-"N)247:QZ1G2YP(F`JAUF,`%$=>(X05.)92E:GE*(``F M9@3.&@^Z.7:`&H@/A_W`.GZ^)*=MW+4 MH.4U0D`_D*_%#8K]O+B4A]K0H9ZA./M(?<7@2QRC""KF;\/6&>E7!&D7!P>3 M*9+2\H[.!A(TCHYA-KO'KI0"CTD3(8PZ>'".U[JV5K?IGD4Z1]10H>^8PAO^ M)4)_9I>:54?DA0/]L3(F?K#74HB'(>D?`WM`0'F`@/L'B`E04)C*9^!B<)Z0 M3F1''(.D>@PZ<@T*(B`!^KPXX;0-(2E2P!SA)0E?B4$A417F_%K+-N'\I8>E M91Y!Q>5*!;*#(3+!N@Z?Q;.UPKR$<2#5LY`4%G+-%Z)R%/[@F*&O%AM],[%F'NV'MXQSF&A9 MIR!E*4M^4XW&SF&N59J,1'LF*U8FY@\FV5A4#/%78JPY2`4YNG0X^''U-TWZ MCNWMN*MIJZ)MM*$>$\M4J1@&_R%>7D4R,DZE69Y(0?)Q!3*CU MZ@)QZ=.*'J'U*W78MUK+4888]$60-61&H),\CSB[L>RJ3<-N1O3CSI629#V2 M[>0B=OEE,V[2_P`7HJPN/,@* M""<28M?JVW2T)"Z%P32DY`$D2$6YN-W<> MGBZJ9#P6$''G+/`9990%[M`=IS+/=#J>8*XVS^XPCMUQG<("0M<2SBWEF/;< MHR\(X"+>HU`LI"P3A2-KB()G>O5%CID4Z4B!J(\:AU%OK;[+=IULT3:ZUP$@ M`">D&1X$RG+#C+L@,M"W*RZZ9Q"ZE:&4]I(GRP(QXYPU*G5,Y=FWN[U?#]*R M4I)S%%S+BRK6"0JYGL%7LL8PR4_KR@1=HK0N5FI!>5^P""J"IU_3/4@.D<`T M'AVKW79[_P"GK^Z55*AI8:4H3`'B0DSD9#(\1V1%9:W.SKI:VQ+ZW$J<"<\Y MG//+V\,YD0:GZG'N)YDB,NT;M[8-MLQ285]5("WYED*Y,.(*9N,M>Y):/HU# M<3#!5-U'UENU1!T\(!R@Z.[(50/+3$1SSH_9VWO;;4WANS?F--*(;21/41(> M&WN>6M:05*G+3G.W04=%%LE*^K,IYNBPH](](/TW5Z MN._^E3MX3L*G=&G0=>G5($B4LLTRF,<>$5#W3^D:VCUR:_7N7E^8?&"E2I:C MI.K&?##'XPR>T+DJT]UO:[N)[.FZS+=S:L(.*JV2<4Y)3(BJ4&^19K% MCQ9W8_4%EV$+,(LSLE5S&,FR6.G^$"<>]0MJI[1KJ6^]D91I><4A34L`=,P2 M!D2<,L8FVC5OW'MU1;=6D*22?%G(\(:N13B*6K,Y&Q:+*/2K[9!NH@X(^$3&4#J#3Q'@ZZ;7U6WO MMU2^[2L)<:5IE+$F1(&(SP(EV0&7S;3EMOTS-.\ZMIS[V6/O.6><:->V7]/% M@.AO=E6_2-SUE=]_4[=:M59L#E.REDE2"I)QREP'SC1+2LBA`:WM+C^H@'2J72/\`:'D.H#RY@'L'Q'C#FTZ4">9)/O,XU8'"7*/=QW'L<&\0 M_0/[./3])AM7UCV&,L/U9'\C6"?]3<+_`)#NG&V]##*ZW#_R#]BHR_JOC;*1 M^=^*+>_3?B(]I#`(!J`J6C,:8F`=.D#Y+LHB;J_LZ:P-?\HLH:^HJ4/MC#7`[0&65.Z;?MGF:,JEV\.;/N/S#2'>19:)"4^$ M61Y-V66J#95FXE(,IT[@*K5-%91RFD8CHI@'0X:_0J=\;H[(;W>CIO54Z&@9 M2F9R!E*>8!!C$5[6Y47D]0U+A9?6\?%,@2)S)`/&?+'G&A9S](DN5JH=WO\` M'I6A$?-=F=86\I!))$#*G45.XR4HD*"(AUZJ``%T'F`<^,MI^NC].]HI=O82 MC5+PMC5CR,\YQI3G3!;J0:FN4I,ID%1E+Y?AQARYK[;4%VX^QGW$X*K;BHS< MA7,US>+[W&6R$KS"%A8T82X56KN6D>[C+%9&4T555I[RQ%0\LR?0.O3R8VN[ M$W3U.V^H,/WZ1(. MG`&\L==?_-=!_P`@'_KX;Z^(4C>Z!"L_(<_XU0WT?4%[?4*`D-8P@-O>7$0[ M_Z!B\`@]0J;7] M(<0?)?2*L%18S]*%34TM7A[P?G.'.H]*IJZ&JIW]RM`' MPE\I00FF?2DHY#J%7OE,[C2L[6+A`15GKD]%X?5D&$G$R[)!_'O&SM')IVZR M2R"Q1U`>?,!#74.!2NZT,4KQH5[?I=9)09I&KP^$DD>R+R@Z<5-33HJA6)], MXD*"0HX!0F!CRG*"(]J7L41/;WW=2N=8G>1!YPDJM0K1CBUXYB:+&04C"+7H ML*_CE9YVSNLZ\B'*:,,*J""[=,RQ#=0`(!KP*7OU$-Q;(U1FDTURSEZU/V+@9ZP+T/4"?SC]HC8#L`_D:V>?Z9\*_\`KNO\ M8==O^O5O_7,:K;?^A4_Z`BX!/`?Z>T>![[H]D6Y^L]WV1WPH]C@WX@_0/[./ M""1(&4<&7F"?N"@30-R\N<^7*6,3QVE]G.1=B.Q[&FV3*U@J-HN=)G+Y)/YFC*R;BM.& M]GN$M8(\K):881K\ZS=J^*53K1+HLJTD)PG($!1Q(P$APX0.7#92-Y>5N]&0U7'XD<>R<^^!6$["W>RN]>0Q+DS MN5PR&&DT6T<:+#,6=[6V-#H>X#7Y86A8,'R!4`Z2MEY#R3!R$0`.#][JCTY9 M(K*?8T^J3C/2B4Y9S(@:9L.[ZF3=36R8["9R]H&$%GF.S%9Z%V@\J=M;#>;5T>0AM#/TH0$Y3F)R"03W06IM1=+;R]@;6I169E2B3C*7'V"'9 MV,NV+FWMBXSS[1\VW'&USD@?'7A_J7>E+?->S7TK982R@I&K$XR)[/JU=Q$=V;;=7;;2V'M*RLS M)3EV82PP]^<4$W_=AW=;NJ[FC[>MC[)V"X/'#F[X.LJ->M=KO!OIPE M#.,6X)[B=5K&'%U'*:$;`9=SC2&+9HZ44*<[:GLJQ+-HA1=(_6JDT>$)UB(` M(^/&L_U3L.JF[4[,VJIG.>ALG5S)EG/$F>,9\]T_NJG444^XD,XQD5]'8T%>-7]6UG%B6!S)66W6I ML+,?76JSS M;)[RTLW3U[9)R,E6BL9\MP,V0R"*3,04%4Q!`1T#BYZ=W]1692O4E6RM;#SN MLRSF`0,9]IX\>R*V]+-J;K6RZP\D%DX82XSY'[(O+E[>/A;L];$MOZ.YVR$G M;/2<98VQ/!4K'?IG]FR=;:M5HB%G!HT9.+PJJD+'^D.Z6>.Q;I-VO3YFBIRD M$6HMLW2_KA=5M#12TZLJ,\93]GLBWJ=XH;-VAMG`#S_9PTZWYB9@R6,H6&?&.=#?NAK^D-./ M2%EH`XK$TC0D:N.,=`DB:_JCG0P:^Z/Z.H M/ZN'T@)P$I>R.0"YBY-)Y1YZ1Y")>8/QMG^'CGD/+-P,FGJ9SGI4I M/ZX3+'A%C*-W;NV9DA))6H[X=N3SSB@8B,ED:&K+P-0#D=E9U(=VD<->8&(` MA[>*HV/=3:R4[?5+5^8@K'<4:@??$X71;JTR56L(_36$'^_*)1?]P;8A&M1= MOMY>UY!L4!U5/G3&IPY!J.@)V,QA'3[`X83:-TZB$;?6A<\1Y+F!_5$/*WZW MP@%RMI"B6!\YLS[<%16O)7>S[5F+V;E>P;S\23"S8ASA&4)Y+9"DW`IAJ*;9 MK3(R:!4Q_``$P`8>6O%K1]/+VW!P-M4-0A7-:?+'O5+X1655W6I2("UU+2TS MR0=Q3!5PRG=)`BK:(OF5F2M>K35T<#HE<1>.H5=]= MK*H@(@HFDX-'$'30?'3C0]IZ*52).W95,4M,,2D.(*O?JF/U>R!/=.IC*1Y5 MN,+?,[Q69D\Y;@(NVTN(GU2`KEW<(S=4:JUNK++& M72AL8XM`I)US"-1,84F3)FU;JG$#+.==3AH*;TL'I]0*IMF4A>X!'A2V-1)E M*96,)GFHB)7X9=DE8X89`X&-H_;3[2NW+MHT=\RQP MVB?W?JAMV+ MY:^"/OFKX/\`+7D*?%?F;T/P+TN@]?Q#XS_P/D:?O^YT\.47JO5#T?FZY&6G M5/X8PW5>F\H^O\KROSM,I]^$\X`_NO\`]N-\1D?S-?D&^9?//Z_X+\M?-OJ_ M>Z^K^$W^.>I\=>GGKX\^-'V3^I4__4>MTX?5EW>;\H"-S_D+S#ZGT_F2_P`O M5.7']W`BK1_M$/BR^FO7UJ:?*GYIOAGXQ_Y?R_G!JC^M\O!J_\6?Q MQ@55_2W4=7F2Q_[F7XI?")8/D_Q3_,7Z3JY>9ZCYF_P MCHT\?/Y<-5']<_+\?G:>STW^''*'J?\`I5K.G3JD/K]1W?5A[H/CL_\`_E'T M,OR1_DV^(?W/HOX/_P`,_FS3H'R^CTW_`%1YFGXM/?ZO'GQFF\_SCYJOX_ZS M,SUZ]/;EX9?"66$'&Q_RE_\`+]-IEAG/^]C!(R^7J37KZM`Z?,Z]=>D=?Q<] @=/'7@0'ESPY]OS@K/F?=EIXREEW1\HOAQV
-----END PRIVACY-ENHANCED MESSAGE-----